<SEC-DOCUMENT>0000886163-15-000011.txt : 20150202
<SEC-HEADER>0000886163-15-000011.hdr.sgml : 20150202
<ACCEPTANCE-DATETIME>20150202164845
ACCESSION NUMBER:		0000886163-15-000011
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150127
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150202
DATE AS OF CHANGE:		20150202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		15567641

	BUSINESS ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		11119 NORTH TORREY PINES ROAD
		STREET 2:		SUITE 200
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lgnd8-krefoehrtitleandcomp.htm
<DESCRIPTION>8-KEXECUTIVECOMP
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>LGND8-KreFoehrtitleandcompensation2015</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s597488255B251539A3674B48020C056A"></a><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><br><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">WASHINGTON, DC 20549</font></div><div style="line-height:120%;text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;font-weight:bold;">______________</font></div><div style="line-height:120%;padding-top:21px;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">FORM 8&#8209;K</font></div><div style="line-height:120%;text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;font-weight:bold;">______________</font></div><div style="line-height:120%;padding-top:21px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the </font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date of Report (Date of earliest event reported): January 27, 2015</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">LIGAND PHARMACEUTICALS INCORPORATED</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:8pt;">(Exact Name of Registrant as Specified in Its Charter)</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;font-weight:bold;">______________</font></div><div style="line-height:120%;padding-top:21px;text-align:left;text-indent:108px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="50%"></td><td width="50%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">77-0160744</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(State or other jurisdiction of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(I.R.S. Employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">11119 North Torrey Pines Road, Suite 200</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">La Jolla, CA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">92037</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Zip Code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:138%;padding-bottom:13px;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(858)&#160;550-7500</font></div><div style="line-height:120%;text-align:center;"><hr></div><div style="line-height:138%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s Telephone Number, Including Area Code)</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">N/A</font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:180%;text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425) </font></div><div style="line-height:180%;text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12) </font></div><div style="line-height:180%;text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font></div><br><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s597488255B251539A3674B48020C056A"></a><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><br><div style="line-height:180%;text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s597488255B251539A3674B48020C056A"></a><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Appointment of Matthew W. Foehr as President and Chief Operating Officer</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 27, 2015, Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) appointed Matthew W. Foehr as the Company&#8217;s President and Chief Operating Officer, effective immediately.  Mr. Foehr was formerly the Company&#8217;s Executive Vice President and Chief Operating Officer.  Mr. Foehr assumed the responsibility as the Company&#8217;s President from John L. Higgins, who remains the Company&#8217;s Chief Executive Officer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The description of Mr. Foehr&#8217;s compensation and employment terms, as well as his biography, is available in the Company&#8217;s most recent definitive proxy statement, filed with the Securities and Exchange Commission on April 21, 2014, and is incorporated herein by reference.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Base Salary Increases and Payment of Bonuses to Named Executive Officers</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On January 27, 2015, the Compensation Committee (the &#8220;Committee&#8221;) of the Board of Directors of the Company approved base salary increases for 2015 and cash bonus payments for the 2014 fiscal year to be paid to the Company&#8217;s named executive officers.  Under the Company&#8217;s bonus program, the target performance bonus for John L. Higgins, the Company&#8217;s Chief Executive Officer, is 75% of base salary, the target bonus for Matthew W. Foehr, the Company&#8217;s President and Chief Operating Officer, is 50% of base salary, and the target bonus for the other named executive officers is 40% of base salary.  Bonus payments were based on the Committee&#8217;s evaluation of performance goals for 2014.  Such goals related to the achievement of certain corporate organizational and infrastructure objectives and the advancement of the Company&#8217;s business and clinical development programs.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2015 base salaries and 2014 bonuses to be paid to each named executive officer are as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.2991452991453%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="46%"></td><td width="3%"></td><td width="24%"></td><td width="3%"></td><td width="24%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name and Title</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015 Base Salary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014 Bonus</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. Higgins,</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$550,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$382,648</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Matthew W. Foehr, President and Chief Operating Officer</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$413,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$187,680</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nishan de Silva, M.D., M.B.A.,</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President of Finance &amp; Strategy and Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$330,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$120,219</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charles S. Berkman, Vice President, General Counsel and Secretary</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$310,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$115,575</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;7.01 Regulation FD Disclosure.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A press release dated February 2, 2015 announcing the appointment of Mr. Foehr is attached hereto as Exhibit 99.1. The information contained in Exhibit 99.1 of this Current Report on Form 8-K is being furnished pursuant to this Item 7.01 and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s597488255B251539A3674B48020C056A"></a><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;9.01 Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d) </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibits</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="12%"></td><td width="6%"></td><td width="82%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit&#160;No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press Release, dated February 2, 2015.</font></div></td></tr></table></div></div><br><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s597488255B251539A3674B48020C056A"></a><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:26px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;padding-bottom:24px;text-align:left;padding-left:240px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="line-height:120%;padding-left:25px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.29059829059828%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="42%"></td><td width="58%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: February 2, 2015</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:   </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/  Charles S. Berkman</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;<br>Name:   Charles S. Berkman <br>Title:   Vice President, General Counsel and Secretary</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s2359F0C823C613DC49164B48023B6D5A"></a><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="12%"></td><td width="6%"></td><td width="82%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit&#160;No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press Release, dated February 2, 2015.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:144px;text-indent:-96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><br><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lgndfoehrnamedpresident.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>LGNDFoehrnamedpresident</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="sB73F6A158191763AD4264B4B3BE6C4DD"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;"><img src="lgndfoehrnamedpresimage1.jpg" style="height:69px;width:196px;"></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:68.359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="51%"></td><td width="49%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contacts:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ligand Pharmaceuticals Incorporated</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LHA</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John L. Higgins, CEO</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bruce Voss, bvoss@lhai.com</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Ligand Promotes Matthew W. Foehr to President</font></div><div style="line-height:144%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SAN DIEGO (February 2, 2015) &#8211; Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)</font><font style="font-family:inherit;font-size:11pt;">&#32;announces that Matthew W. Foehr, currently Executive Vice President and Chief Operating Officer, has been promoted to President and Chief Operating Officer of Ligand.  John Higgins, who had been serving as President and Chief Executive Officer, will continue to serve as the Company&#8217;s Chief Executive Officer.  </font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;I am delighted to share with our investors and partners news of Matt&#8217;s promotion to President,&#8221; said John Higgins, Chief Executive Officer of Ligand.  &#8220;Matt is an accomplished pharmaceutical executive and a fantastic colleague who has played a critically important role in helping build Ligand over the past several years. He is a perfect fit for our business, driving excellence in operations, managing successful programs with tight financial discipline and having keen vision for how to strategically grow our business.  Ligand&#8217;s internal team and our partners know Matt for his strong commitment to the customer, untiring energy and sense of humor.  His contributions to Ligand over the past four years have been profound.  On behalf of my colleagues and the Ligand Board of Directors, I extend deep congratulations to him on this well-deserved promotion.&#8221;</font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Mr. Foehr has more than 20 years of experience in the pharmaceutical industry, having managed global operations and various research and development programs.  Prior to joining Ligand in 2011, he was Vice President and Head of Consumer Dermatology R&amp;D, as well as Acting Chief Scientific Officer of Dermatology, in the Stiefel division of GlaxoSmithKline (GSK).  GSK acquired Stiefel in 2009 for $3.6 billion.  At Stiefel Laboratories, Inc., Mr. Foehr served as Senior Vice President of Global R&amp;D Operations, Senior Vice President of Product Development &amp; Support, and Vice President of Global Supply Chain Technical Services.  Prior to Stiefel, Mr. Foehr held various executive roles at Connetics Corporation, including Senior Vice President of Technical Operations and Vice President of Manufacturing.</font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Mr. Foehr serves on the Board of Directors of Ritter Pharmaceuticals, Inc. and Viking Therapeutics Inc.  He is the author of multiple scientific publications and is named on numerous U.S. patents.  He received a Bachelor of Science degree in Biology from Santa Clara University.</font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">About Ligand Pharmaceuticals</font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Ligand is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty generating assets and coupling them with a lean corporate cost structure. Ligand&#8217;s goal is to produce a bottom line that supports a sustainably profitable business. By diversifying the portfolio of assets across numerous technology </font></div><br><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sB73F6A158191763AD4264B4B3BE6C4DD"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">types, therapeutic areas, drug targets and industry partners, we offer investors an opportunity to invest in the increasingly complicated and unpredictable pharmaceutical industry. In comparison to its peers, we believe Ligand has assembled one of the largest and most diversified asset portfolios in the industry with the potential to generate revenue in the future. These therapies seek to address the unmet medical needs of patients for a broad spectrum of diseases including diabetes, hepatitis, muscle wasting, Alzheimer&#8217;s disease, dyslipidemia, anemia, asthma and osteoporosis.  Ligand&#8217;s Captisol platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs.  Ligand has established multiple alliances with the world's leading pharmaceutical companies including GlaxoSmithKline, Onyx Pharmaceuticals (a subsidiary of Amgen Inc.), Merck, Pfizer, Baxter International, Lundbeck Inc., Eli Lilly &amp; Co. and Spectrum Pharmaceuticals.  Please visit www.captisol.com for more information on Captisol and www.ligand.com for more information on Ligand.</font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Follow Ligand on Twitter @Ligand_LGND.</font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">#   #   #</font></div><br><div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lgndfoehrnamedpresimage1.jpg
<TEXT>
begin 644 lgndfoehrnamedpresimage1.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X0!817AI9@``34T`*@````@`!`$Q``(`
M```1````/E$0``$````!`0```%$1``0````!```N(U$2``0````!```N(P``
M``!!9&]B92!);6%G95)E861Y``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`(+!<8#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`KB-?\`B-;Z;=SV5C:-<3Q,T;R2':BN..!U8`Y!Z=.#SFNWKYQH
M`ZR[^(WB"YV>5);VNW.?)A!W?7?N_3'6J_\`PGOB7_H)?^0(_P#XFN;HI@=)
M_P`)[XE_Z"7_`)`C_P#B:DM_B#XCAG622[CG49S')"H4\=]H!_6N7HH`],TG
MXGQ2/'%JMGY6>&G@)*@Y[H>0`.N"3QTYKT".1)HDEB=7C=0RLIR&!Z$'N*^<
MZ]M\#2/+X,TYI'9V"NH+')P'8`?0``?A2`Z&BBB@`HHHH`****`(+R\M["TE
MNKJ58H(EW.[=`/ZGV[UY;KGQ'U"^WPZ:GV*W.1YG65AR.O1>".G((^]5+QMX
MDEUK5I+>&;.GVSE8E4C#L."^03GG.#Z>F3G8\*^$[*'1)/$&M0M-&L;3Q6V"
M,(O.X@XW$XX!XP><YX`.7M=$U_Q#*;F*UNKIG7=]HE;`<#Y?OL<$CIC/;VJS
M)X&\211/(VF,512Q"RHQP/0!LD^PKN/^%GZ+_P`^NH?]^T_^+H_X6?HO_/KJ
M'_?M/_BZ8'`V.NZ[X;N5@2:XA\K@VEP#M`)#8V'IGU&#SUYKTGPKXUM_$#?9
M;B-;:_"Y"!LK*`.2OH>OR\\=SSB21=`\?:6`LC,8F!RORRP$C..0>#T[@XXY
M&1Y3JVFW?A[69+:0R1R0ONAE'REES\KK@\=/7@\=10![Y17/>#?$!U_1%DG=
M3>0-Y<X``R>S8!Z$?3D-@<44@.AHK-U37]*T;:-0O8X6;&$Y9B#GG:,G'!YQ
MBN>D^)NAI*Z+#?2*K$!UC7##U&6!Q]0*`.SHKSJ3XJH)7$6CLT88[6:XVDCL
M2-IP?;)IO_"UO^H+_P"37_V%`'H]%<':_%+3GB)N]/NHI-W"Q%9!CUR2O/7C
M%;-AXZ\/W_EK]M^SROGY+A2FW&>K?='3U_7B@#HZ***`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OG&OHZOG&@`HHHI@%%%
M%`!7M?@+_D2]/_[:?^C&KQ2O:_`7_(EZ?_VT_P#1C4`='1112`****`"L?Q7
M?OIOA?4+J+=Y@CV*5;:5+$*&!]1NS^%;%<YX]_Y$O4/^V?\`Z,6@#RCPYIHU
M;Q%8V3A3')(#(&)`*+\S#(YR0"*]H\0_\BUJO_7G-_Z`:\G\!?\`(Z:?_P!M
M/_1;5ZQXA_Y%K5?^O.;_`-`-`'CWA&PMM4\3V=G>1>;;R;]Z;BN<(Q'((/4"
MNQ\8>"M(L="EO[$?8WM^6!9W60$@;><D')&#TYY]1YY8?;?ML?\`9WVC[7SY
M?V?=OZ'.-O/3/X59U;^V_P!S_;']H?Q>5]LW^V=N[\,X]J8&IX`D=/&=DJ.R
MJZR*X!P&&QC@^HR`?P%==\3-)6XTF'4XX_WMLX21A@?NV]>YPV,>FXU2^&+Z
M47G189%U548M(S$J\1*]!T&"!UYYZ]ATGCW_`)$O4/\`MG_Z,6D!YQX-\10>
M'=3GFNA</;RP[#'#@Y;(()!('`W?G[T5S=%,">\O+B_NY;JZE:6>5MSNW4G^
M@]NU0444`%%%%`!1110!ZI\,=2EN=)NM/D&5M'!C;C[KY.W&.Q!.?]KVKNJ\
MX^%/_,7_`.V/_L]>CT@"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"OG&OHZOG&@`HHHI@%%%%`!7M?@+_`)$O3_\`MI_Z,:O%
M*]K\!?\`(EZ?_P!M/_1C4`='1112`****`"J6L6/]IZ->606,M-"R)Y@^4-C
MY2?H<'\*NT4`?/5O-/I>IQ3>7MN+68/Y<BD893G##@]1S7M6HWT&I^"KZ]MV
MS%-82NO(R/D/!QW!X/N*X_Q]X1E6>;6[!-\;?-<Q*H!0XY<8Z@]3W!R>A..;
M\,^)I="G>&9/M&FW'%Q;,`001@L`>,X[=".#V(8$O@+_`)'33_\`MI_Z+:O1
M_'5A]O\`"5WMBWRV^)T^;&W:?F/7GY2W']<4S1=1\(W30W&GIIMO<E@J*8DB
ME#$?=`X)/..,@\C)K=OKBRM[9O[0FMXK>3]V?M#*JMD'Y>>#D9XI`>-^![P6
M?B^Q9Y6CCE9HFQG#%E(4''4;MOZ'M72?$_6$=K;1X]K,C>?,>I4X(4=>#@DD
M$=UIOB3Q'X9M8);;1]*T^>[/R^?]D3RX^2"1D?,>./X><Y/0\9INFW_B#5!;
MVX::XE8N\CDD`9Y=CZ<]?YDTP.J^&^B0:A<WMY>6T<UO&@B1)H0ZLQ.203QD
M`#_OK\RO1=%TFWT32X;&W5<(HWN%P9'QRQZ\GZ\<#H**0'@%%%%,`HHHH`**
M**`/1_A3_P`Q?_MC_P"SUZ/7G'PI_P"8O_VQ_P#9Z]'I`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%?.-?1U?.-`!1113`**
M**`"O:_`7_(EZ?\`]M/_`$8U>*5[7X"_Y$O3_P#MI_Z,:@#HZ***0!1110`4
M444`%<9X@^'EAJ3/<:<RV-QM_P!6J#RF(![#[I/'(].A)KLZ*`/&[KX=^(;>
M4)%;PW*E<[XIE`!]/FVG/X=ZA_X0+Q+_`-`W_P`CQ_\`Q5>U44`>5Z3\,]0N
M'CDU.>.UBZM'&=\G7I_=&1GG)QQQ7HNDZ+8:):+;V,"H-H#R$#?(1GECW/)^
MF>,"K]%`!1110!\XT444P"BBB@`HHHH`]'^%/_,7_P"V/_L]>CUYQ\*?^8O_
M`-L?_9Z]'I`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`52O]7T_3%)O+N*
M(@!MA.6()QD*.3^5<;XM\6S?:)--TV1XA$^V:9258L#]U3U`!ZGO].O$5Y.)
MS14Y.%-7\^A[&%RJ52*G4=D^G4]5F\;:%%$SI<O,PZ(D3`G_`+Z`'ZU4_P"%
MA:3_`,^][_WPG_Q5>:T5PO-<0]K+Y'='*<.M[OYGJL/C;0I8E=[EX6/5'B8D
M?]\@C]:U+#5]/U-0;.[BE)!;8#A@`<9*GD?E7BU%:0S>JG[T4_P(GD])KW9-
M?B>[45P'A+Q;-]HCTW4I'E$K[89F)9@Q/W6/4@GH>WTZ=_7LX?$0KPYHGB8G
M#3P\^284445N<X4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!7SC7T=7SC0`4444P"BBB@`KVOP%_P`B7I__`&T_]&-7BE>U^`O^
M1+T__MI_Z,:@#HZ***0!1110`4444`%%%%`!1110`4444`%%%%`'SC1113`*
M***`"BBB@#T?X4_\Q?\`[8_^SUZ/7G'PI_YB_P#VQ_\`9Z]'I`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!6=KM^=-T.\NU+!TCPA4`X8\*<'W(K1KE_'TTD7AU
M41L++.J.,=1@MC\U'Y5AB9N%&4EV-\-!5*T8OJSS&BBBOD#[,****`"BBB@`
MKVO2[S^T-*M;LE"TL2LVP\!L<C\#D?A7BE>L^#?^13LO^VG_`*&U>ME$FJLH
M^7]?F>/G,4Z49=G^?_#&[1117T!\Z%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`5\XU]'5\XT`%%%%,`HHHH`*]K\!?\B7I_P#V
MT_\`1C5XI7M?@+_D2]/_`.VG_HQJ`.CHHHI`%%%%`!1110`4444`%%%%`!11
M10`4444`?.-%%%,`HHHH`****`/1_A3_`,Q?_MC_`.SUZ/7G'PI_YB__`&Q_
M]GKT>D`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%<G\0O\`D`0?]?2_^@O765S'
MCRW>?PV9%*@03)(V>XY7C\6%<N-3>'G;L=6":6(A?N>84445\F?8!1110`44
M44`%>G>`89(O#K.ZX66=G0YZC`7/YJ?RKS&O6O!Z/'X5L5=64D.V&&."[$'\
M00:]/*8WKM]E_D>5F\K4$N[_`,S<HHHKZ,^:"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`*^<:^CJ^<:`"BBBF`4444`%>U^`O^
M1+T__MI_Z,:O%*]K\!?\B7I__;3_`-&-0!T=%%%(`HHHH`****`"BBB@`HHH
MH`****`"BBB@#YQHHHI@%%%%`!1110!Z/\*?^8O_`-L?_9Z]'KSCX4_\Q?\`
M[8_^SUZ/2`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBLW_A(=%_Z#&G_^!*?XT`:5%8%QXV\.6T[0R:I&67&3&C2+TSPR
M@@_G4?\`PGOAK_H)?^0)/_B:`.CHKGH_'/AN65(UU-0SL%!:)U&3ZDK@#W-7
M_P#A(=%_Z#&G_P#@2G^-`&E13(9HKB)989$DC;HZ,"#^(I]`!1110`4444`%
M4M7L!J>DW5F0I,L9";B0`W52<>A`-7:*4HJ2<7LRHR<9*2W1X6Z/%(T<BLCJ
M2K*PP01U!%-KT;Q/X-_M"5KW30B7#9,L1.!(?4>C'\CUXYSP5YIUYI\FR\MI
M8220-ZD!L=<'H?PKY/$86I0DU):=SZ[#8NG7BG%Z]BM1117,=0445=L-(U#4
MV`L[264$E=X&%!`S@L>!^=.,7)VBKLF4HQ5Y.R*T$,ES<1P1+NED<(BYQDDX
M`YKVVUMTL[."VC+%(8UC4MU(`P,_E7/^&?"D>BYN;HI->G(#+RL8_P!G/<]S
M^'KGI:^CR["2HQ<I[L^:S+%QKR48;+\0HHHKTCS`HHHH`****`"BBB@`HHHH
M`**J76JZ=8RB*[O[6WD*[@LLRH2/7!/3@U4N/%&A6T#32:M9E5QD1RB1NN.%
M7)/Y4`:U%<Y_PGOAK_H)?^0)/_B:/^$]\-?]!+_R!)_\30!T=%85KXR\/7DI
MCBU2%6"[LRAHACZL`,\]*M_\)#HO_08T_P#\"4_QH`TJ*;'(DT22Q.KQNH96
M4Y#`]"#W%.H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHK-_X2'1?^@QI_\`X$I_C0!I45SG_">^
M&O\`H)?^0)/_`(FC_A/?#7_02_\`($G_`,30!T=%9<?B30Y8DD75[$*ZA@&G
M53@^H)R#[&KMK>6M]$9;2YAN(PVTM%('`/ID=^10!/1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`454NM5TZQ
ME$5W?VMO(5W!99E0D>N">G!JE=>*]`LXA)+JUJREMN(G\TY^BY...M`&Q17.
M?\)[X:_Z"7_D"3_XFG1^.?#<LJ1KJ:AG8*"T3J,GU)7`'N:`.AHK-_X2'1?^
M@QI__@2G^-:5`!1110`4444`%%%%`!7SC7T=7SC0`4444P"BBB@`KVOP%_R)
M>G_]M/\`T8U>*5[7X"_Y$O3_`/MI_P"C&H`Z.BBBD`4444`%%%%`!1110`44
M44`%%%%`!1110!\XT444P"BBB@`HHHH`]'^%/_,7_P"V/_L]>CUYQ\*?^8O_
M`-L?_9Z]'I`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110!RNO>/=,T:62VB#7EVC;6CC.U4(QD,WKR>@/(P<5R<GQ0U<RN8K
M.Q6,L=JLKL0.P)W#)]\"N+N+B6[N9;B9MTLKEW;`&6)R3@>]1TP.HN/B#XCF
MG:2.[C@4XQ''"I4<=MP)_6H_^$]\2_\`02_\@1__`!-<W10!VO\`PL_6_P#G
MUT__`+]O_P#%ULZ;\4+>66./4K%H%*@--$^\;N,G;C(7J>I/UKS&B@#Z,CD2
M:))8G5XW4,K*<A@>A![BG5SG@+_D2]/_`.VG_HQJZ.D`4444`%%%%`!1110`
M4444`%%%9NLZ[I^@VPFOYMF_(CC49:0@9P!_4X'(R1F@#2K-U37]*T;:-0O8
MX6;&$Y9B#GG:,G'!YQBO+]:^(.KZIF.U;[!;G^&%OG/3J_!Z@],<'!S7)T`>
MCW_Q3_UB:=IOIY<MP_TSE%_$?>]_:N7OO&OB"_W!]1DA0OO"VX$>WKQD?,1S
MW)K`HI@27%Q/=SM-<3232MC=)(Q9C@8Y)]JCHHH`****`"BBB@`K;M/%_B"R
MW^5JMPV_&?.(EZ>F_..O:L2B@#T73?BDX8+JFGJ5+',EJ<$#'`VL>3GON'7V
MY[/2?$ND:RD?V2\C\U^/(D.V0'&2-IZX'<9'!YKP>B@#Z.HKQW1?B#J^EXCN
MF^WVX_AF;YQUZ/R>I'7/`P,5Z=H_B'3-=B#6-RK2!<M"WRR+TSE?09`R,C/>
MD!J4444`%%%%`%)]'TR61I)-.M'=B69F@4DD]23BF_V)I/\`T"[+_P`!T_PJ
M_14>SAV1?M9_S,J0Z5I]M*LL%A:Q2KT=(54CMU`JW115**CHD3*3EJV%%%%,
M04444`%%%9NJ:_I6C;1J%['"S8PG+,0<\[1DXX/.,4`:5%>8ZM\3[B1FCTFU
M6*,J1YMP-SY('(4'`(.>N[/'TKC]2US4]78F_O9IE+!MA;"`@8R%'`./0=S0
M!Z[J7C?0--4YO5N9-H81VO[PD$XZCY0>^"1_*N9O_BG_`*Q-.TWT\N6X?Z9R
MB_B/O>_M7G%%,#IKSQ]XANVEVWBV\<B[?+AC4!1C'!.6![YS]*PKO4;V_P!G
MVR\N+C9G9YTK/MSUQD\=!5:B@`HHHH`****`"BBB@`K6M_%&NVTZS1ZM>%ES
M@22F1>F.5;(/Y5DT4`=K8?$S5[?RUO(+>[1<[VQY;MUQR/E&./X>@_&NMTSX
MAZ)?;4N'DLI3M&)ERI8]<,.P/=L?SQX[10!]%6]Q!=P+-;S1S1-G;)&P93@X
MX(]ZDKY^TW5]0T><S:?=R0,?O!3E6X(Y4\'J>HXKT70?B3;WDL=MJT*VTKMM
M$\9_=9.?O`\J.@SD^IP*0'>44V.1)HDEB=7C=0RLIR&!Z$'N*=0`4444`%%%
M%`!1110`4444`<AX@^(%AHUV]G;P->W$;8DVN%1#SD;L'+#CC'?KD8KE?^%G
MZW_SZZ?_`-^W_P#BZXZXN);NYEN)FW2RN7=L`98G).![U'3`Z3_A/?$O_02_
M\@1__$U);_$'Q'#.LDEW'.HSF.2%0IX[[0#^M<O10!W5O\4=46=3<6-G)%SN
M6/<C'CL23CGVKM_#GBJP\1Q,(-T-S&H,D$A&0..5/=<\9_,#(KPZNH^'UQ+#
MXQM8XVPLR2)(,#E=I;'YJ#^%`'LU%%%(`HHHH`*;)(D,3RRNJ1HI9F8X"@=2
M3V%<=X@^(=AIK/;Z<JWUQM_UBN/*4D'N/O$<<#UZ@BO.-8\0ZGKLI:^N6:,-
ME85^6->N,+ZC)&3DX[T`>DZM\1](L'DBM$DOI5XS'\L><X(W'VYR`0>.:XJ^
M^('B"]W!+B.U1DV%;>,#UYR<L#SV(Z5R]%,">ZO+J^E$MW<S7$@7:&ED+D#T
MR>W)J"BB@`HHHH`****`-:Q\3ZWIVT6VIW`54V*CMYBJO&`%;('3L*ZC3/B?
M=Q;8]3LXYU^4&6$[&Q_$Q!R">^!M'].!HH`]ZT?Q#IFNQ!K&Y5I`N6A;Y9%Z
M9ROH,@9&1GO6I7SG'(\,J2Q.R2(P964X*D="#V-=MX?^(U[9,D&K!KNV"X$B
M@>:O`QSD!AQWYYSD]*0'JU%06=Y;W]I%=6LJRP2KN1UZ$?T/MVJ>@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`***Y/Q%X\T_1_.M;4_:K],KM`^2-N
M/O'OU/`SR"#B@#JI)$AB>65U2-%+,S'`4#J2>PKE]6^(&BZ8S10R->S!3@6^
M"@.`0"_3!SU&<8->7ZQXAU/792U]<LT8;*PK\L:]<87U&2,G)QWK+H`[/4OB
M5K%TQ%DD-E'N!!"^8^,<@EN",\_=';\>9OM8U+4]PO;ZXG4OOV/(2H;GD+T'
M4]!5*BF`4444`%%%%`!4]K>75C*9;2YFMY"NTM%(4)'ID=N!4%%`'6:9\0];
ML=J7#QWL0VC$RX8*.N&'<CNV?YY[;1?B#I&J8CNF^P7!_AF;Y#UZ/P.@'7')
MP,UX[10!]'45X9HOBO5]"PEK<;[<?\N\WS)WZ#JO))X(R>N:]4\/^+M-\0($
MC?R+L8!MY6&XG&3M_O#@^_'(%(#?HHHH`*^<:^CJ^<:`"BBBF`4444`%>U^`
MO^1+T_\`[:?^C&KQ2O:_`7_(EZ?_`-M/_1C4`='1112`****`"BBB@`HHHH`
M****`"BBB@`HHHH`^<:***8!1110`4444`>C_"G_`)B__;'_`-GKT>O./A3_
M`,Q?_MC_`.SUZ/2`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@#YQHHHI@%%%%`!1110![7X"_Y$O3_^VG_HQJZ.N<\!?\B7
MI_\`VT_]&-71T@"BBB@`HHHH`****`"BBN!\;>-OL?F:5I4O^D\K/<*?]5ZJ
MI_O>I[?7H`6?%?CR#2_/T_33YM^ORM+@%(CW^K#TZ`GGH17EMY>7%_=RW5U*
MTL\K;G=NI/\`0>W:H**8!1110`4444`%%%%`!1110`4444`%%%%`!1110`5/
M9WEQ87<5U:RM%/$VY'7J#_4>W>H**`/6?"GCR#5/(T_4CY5^WRK+@!)3V^C'
MTZ$CCJ!7:U\XUZAX)\;?;/+TK59?])X6"X8_ZWT5C_>]#W^O5`=]1110`444
M4`%%%%`!1110`56OM0M-,MFN+VXC@B'\3G&3@G`'<X!X'-0ZUJ]OHFES7UPR
MX13L0M@R/CA1UY/TXY/05XEK.NZAKUR)K^;?LR(XU&%C!.<`?U.3P,DXH`ZC
MQ!\1[F^0V^D))9Q'(:9L>8P(Q@==O)/()/3D5P\DCS2O+*[/([%F9CDL3U)/
M<TVBF`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!TWACQE
M>Z!+%!*S3Z;N.Z#C*YZE#V/?'0Y/0G->PV=Y;W]I%=6LJRP2KN1UZ$?T/MVK
MYXKH?"OBJX\.7>UMTMA*W[Z$'D'^\OHW\^A[$`'MM%1V]Q%=VT5Q`VZ*5`Z-
M@C*D9!P?:I*0!1110`4444`%%%%`'SC1113`****`"ND\!?\CII__;3_`-%M
M7-UTG@+_`)'33_\`MI_Z+:@#VJBBLGQ!X@M/#NGFXN#OE;(AA!PTC?T`[GM]
M2`4!;U+4[+2+0W5_<+#"&"[B"22>P`Y)^GH:\F\2^.+_`%MGM[8M:V&X@(A(
M>12,?.0>1UX''/.<`UCZSKNH:]<B:_FW[,B.-1A8P3G`']3D\#).*S:8!111
M0`4444`%%%%`!1110`4444`%%%%`!1110!K>'_$%WX=U`7%N=\;8$T).%D7^
MA'8]OH2#[%X?\06GB+3Q<6YV2K@30DY:-OZ@]CW^H('@]:6A:S/H.K0W\(W[
M,J\98@2*>H./S'7D`X.*`/?**I:3JUIK6GQWME)OB;@@\,C=U8=B/_K]#5VD
M`4444`%%%%`!1110`4444`%%%%`!39)$AB>65U2-%+,S'`4#J2>PJ*\O+>PM
M);JZE6*")=SNW0#^I]N]>,^*O%5QXCN]J[HK")OW,)/)/]YO5OY=!W)`-3Q7
MX\GU3S]/TT^58-\K2X(>4=_HI].I`YZD5Q5%%,`HHHH`****`"BBB@`HHHH`
M****`"BBB@`IT<CPRI+$[)(C!E93@J1T(/8TVB@#T?PI\0?]1IVLM_LK>LWY
M!_U^;/IGN:]%CD2:))8G5XW4,K*<A@>A![BOG.NO\&^,GT.5;*]9GTUVX/4P
M$]QZKZC\1SD%`>OU\XU]#V=Y;W]I%=6LJRP2KN1UZ$?T/MVKYXH`****8!11
M10`5[7X"_P"1+T__`+:?^C&KQ2O:_`7_`")>G_\`;3_T8U`'1T444@"BBB@`
MHHHH`****`"BBB@`HHHH`****`/G&BBBF`4444`%%%%`'H_PI_YB_P#VQ_\`
M9Z]'KSCX4_\`,7_[8_\`L]>CT@"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`^<:***8!1110`4444`>U^`O^1+T_P#[:?\`
MHQJZ.N<\!?\`(EZ?_P!M/_1C5T=(`HHHH`****`"BBH+R\M["TENKJ58H(EW
M.[=`/ZGV[T`<]XT\4?\`"/Z>L5J\9U"?A%/)C7G+X^O`SW]<$5XS6AK6KW&M
MZI-?7#-EV.Q"V1&F>%'3@?3GD]36?3`****`"BBB@`HHKNO#_P`.+F^07&KO
M)9Q'!6%0/,8$9R>NWDC@@GKP*`.'CC>:5(HD9Y'8*JJ,EB>@`[FMNU\&^(;R
M(R1:7,JAMN)2L1S]&(..>M>R:;I&GZ/`8=/M(X%/WBHRS<D\L>3U/4\5=I`>
M3?\`"L-;_P"?K3_^_C__`!%'_"L-;_Y^M/\`^_C_`/Q%>LT4`>17'PTUV&!I
M(WLYV&,1QRD,>>VX`?K63=^$/$%EL\W2KAM^<>2!+T]=F<=>]>YT4`?.-%>]
M:QX>TS78BM];*T@7"S+\LB]<8;T&2<'(SVKSCQ!\/+_35>XTYFOK?=_JU0^:
MH)/8?>`XY'KT`%,#C****`"BBB@`HHHH`]F\%^*/^$@T]HKIXQJ$'#J.#(O&
M'Q]>#COZ9`KJ*\!T75[C1-4AOK=FRC#>@;`D3/*GKP?IQP>HKWJWN(KNVBN(
M&W12H'1L$94C(.#[4@)****`"BBB@`HHHH`\V^*=X#+IUDLK;E5Y9(^<8.`I
M/8GAQ[<^M>=5VOQ/_P"1EMO^O-?_`$-ZXJF`4444`%%%%`!13HXWFE2*)&>1
MV"JJC)8GH`.YKI--\!:_J*AS;+:1E20UTVPD@XQM`+`_4?TH`YFBO4K#X7V$
M,N^^OIKE0P*I&@B!`ZAN22#QT(KI+7PIH%G$8XM)M64MNS*GFG/U;)QQTH`\
M)K0CT+5YHDEBTJ^>-U#*RV[D,#T(..17OD<:0Q)%$BI&BA551@*!T`'84ZD!
MX'_PCVM_]`?4/_`9_P#"FR:%J\,3RRZ5?)&BEF9K=P%`ZDG'`KWZB@#YQHKZ
M*N+>"[@:&XACFB;&Z.10RG!SR#[UA:EX(T#4E.;);:3:%$EK^[(`.>@^4GMD
M@_RI@>)45WFK?#*]MU:72[E;I=QQ#(`C@9&`#G!.,Y)V]/?%</<6\]I.T-Q#
M)#*N-T<BE6&1GD'VH`CHHHH`****`"BBB@#T/X;>(&2<Z%.<H^Z2W8DDAL9*
M8Z`8!;MSGKFO2Z^=;>XEM+F*XA;;+$X=&P#A@<@X/O7OND:E%K&DVVH0C"S)
MDKS\K=&7)`S@@C/?%("[1110`4444`%%%%`'SC1113`****`"ND\!?\`(Z:?
M_P!M/_1;5S=:GAW54T37(-1DC:585?"*<%B48`9[#)'/\Z`/9/$'B"T\.Z>;
MBX.^5LB&$'#2-_0#N>WU(!\4U;5KO6M0DO;V3?(W``X5%[*H[`?_`%^IHU;5
MKO6M0DO;V3?(W``X5%[*H[`?_7ZFJ5`!1110`4444`%%6;'3[O4[E;>RMY)Y
M3_"@S@9`R3V&2.3Q77Z;\,M3N5#W]S#9J5/R@>:X.>A`(&,<Y!/;\`#AZ*]?
MM?AOH%O*7E%U<J5QLEEP`?7Y0IS^/>KG_"!>&O\`H&_^1Y/_`(J@#Q2BO:)/
M`'AMXG1;!HV92`ZSOE3ZC)(S]0:Q[OX663[/L>I7$.,[_.19,^F,;<=_6@#R
M^BM_5O!FMZ0DDLUKYUNG6:`[UQC))'W@!@Y)`%8%`!1110`4444`%%%%`'5>
M!_$IT35!;7$C?8+E@K`L`L;D@!^>@['D<<\X`KV2OG&O9/`6O/K.B&*YD:2[
MM&"2,QR74_=8G'7@CN?ER>M(#JJ***`"BBB@`HHHH`****`"BBN*^(7B/^SM
M/_LJW;%U=I^\RF0L)R#SZDC'?C/3@T`<SXY\6/JMW)IME,ITZ)AN:,Y$[#N3
M_=!Z#H<9YXQQE%%,`HHHH`****`"BBB@`HKJ-)\`ZWJ3QM-!]BMVY,D_#`9P
M<)][/4C.`<=:ZRQ^&&FP[6O;RXN6#YP@$:E>/E(Y/KR".M`'E=%>VQ^!O#<4
MJ2+IBED8,`TKL,CU!;!'L:MW'A?0KF!H9-)LPK8R8XA&W7/#+@C\Z`/!Z*]F
MN/A]X<F@:..TD@8XQ)',Q8<]MQ(_2L+4OA:A4MI>H,&"C$=T,@G/)W*.!CMM
M/3WX`/-J*U-8\/:GH4I6^MF6,MA9E^:-NN,-ZG!.#@X[5ET`%%%%`!1110!T
M/A7Q5<>'+O:VZ6PE;]]"#R#_`'E]&_GT/8CGJ**`"BBB@`HHHH`*]K\!?\B7
MI_\`VT_]&-7BE>U^`O\`D2]/_P"VG_HQJ`.CHHHI`%%%%`!1110`4444`%%%
M%`!1110`4444`?.-%%%,`HHHH`****`/1_A3_P`Q?_MC_P"SUZ/7G'PI_P"8
MO_VQ_P#9Z]'I`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110!\XT444P"BBB@`HHHH`]K\!?\B7I__;3_`-&-71USG@+_`)$O
M3_\`MI_Z,:NCI`%%%%`!1110`5Y[\3]6:."TTJ*3'FYFF49!*@X49Z$$[CCU
M4=*]"KP7Q'J0U;Q%?7J%3')(1&5!`*+\JG!YR0`:`,NBBBF`4444`%%%=U\.
M/#ZWUZVKW`S%:OMB4@$-)CJ?3:""..I'/%`&MX)\$_8_+U758O\`2>&@MV'^
MJ]&8?WO0=OKT[ZBBD`4444`%%%%`!1110`4444`<#XV\$_;/,U72HO\`2>6G
MMU'^M]64?WO4=_KU\OKZ.KR;XA>'/[.U#^U;=<6MV_[S+Y*S')/'H0,]^<].
M!0!Q5%%%,`HHHH`*]0^&>M>?93:/*?GM\RP\=4)^8=.S'/)R=WM7E];'A74G
MTKQ)93K*L<;2"*8NV%\MCAL\C@=>>,@'M0![M1112`****`"BBB@#RGXH1N/
M$%K*481M:A5;'!(=L@'U&1^8KAZ]9^)6DRWVC07L$<DCV;L7"XP(V'S,1U."
MJ].@R?IY-3`**='&\TJ11(SR.P5549+$]`!W-=YHOPSN9\2ZQ/\`9D_YXPD,
MYZ]6Y4=CQG(/:@#BK'3[O4[E;>RMY)Y3_"@S@9`R3V&2.3Q7;Z3\,+B1EDU:
MZ6*,J#Y5N=SY(/!8C`(..F[//UKT6QT^TTRV6WLK>."(?PH,9.`,D]S@#D\U
M9I`4--T/3-(4"PL886"E=X7+D$YP6/)&?4]A5^BB@`HHHH`****`"BBB@`HH
MHH`*Q_$'ANP\0VCQW$:I<;<1W*J-Z$9QSW7D\>_8\UL44`>#^(/#]WX=U`V]
MP-\;9,,P&%D7^A'<=OH03DU[MXE\/V_B'2WMY$7[0BEK>4G!1\>N#\IXR/Z@
M5X;<6\MI<RV\R[98G,;KD'#`X(R/>F!'1110`4444`%>D_"W4@8K[2V*A@PN
M(Q@Y(.%;)Z8&$_,]>WFU;_@J^^P>+;!RT@25_)8(?O;QM&?4;BI_"@#V^BBB
MD`4444`%%%%`'SC1113`****`"BBB@`HHHH`***GL[.XO[N*UM8FEGE;:B+U
M)_H/?M0!!7=>'_AQ<WR"XU=Y+.(X*PJ!YC`C.3UV\D<$$]>!72^%?`]OHB_:
M;\0W5^6RI`W)$`<C;D?>X!SCCH.Y/7T@*UCI]IIELMO96\<$0_A08R<`9)[G
M`')YJS110`4444`%%%%`!7'>*/`=MK&^ZT\1VU^S[G+$A)<]<@9P>^0.3G/7
M([&B@#YXO+.XL+N6UNHFBGB;:Z-U!_J/?O4%>S>-/"__``D&GK+:I&-0@Y1C
MP9%YRF?KR,]_3)->,TP"BBB@`HHHH`*Z;P+K#Z5XD@B^8P7C""11ZD_*<9`R
M#W]"U<S10!]'450T/4AJ^B6=^"I::,%]H(`<<,!GG`8$5?I`%%%%`!1110`4
M444`5M0OH-,T^>]N&Q%"A=N1D^PSW)X'N:\#U"^GU/4)[VX;,LSEVY.![#/8
M#@>PKOOB9KG^IT6!_26XVG_OE3@_\"((_NFO.*8!1110`4444`%%%7=)TF[U
MK4([*RCWR-R2>%1>[,>P'_UNIH`-)TF[UK4([*RCWR-R2>%1>[,>P'_UNIKU
MGPWX)T_18(IKB*.ZU`?,TS#*H<@X0'I@CAL9Z],X&EX?\/VGAW3Q;VXWRM@S
M3$8:1OZ`=AV^I).M2`****`"BBB@`HHHH`*XK7/AQI]]OGTU_L5P<GR\9B8\
MGIU7DCIP`/NUVM%`'SU?:?=Z9<M;WMO)!*/X7&,C)&0>XR#R.*K5[_JVBV&M
MVC6]]`KC:0D@`WQDXY4]CP/KCG(KQWQ'X5O_``Y*IGVS6TC$1SQ@X)YX8=FQ
MSC\B<&F!A4444`%%%%`!1110`4444`%>U^`O^1+T_P#[:?\`HQJ\4KVOP%_R
M)>G_`/;3_P!&-0!T=%%%(`HHHH`****`"BBB@`HHHH`****`"BBB@#YQHHHI
M@%%%%`!1110!Z/\`"G_F+_\`;'_V>O1Z\X^%/_,7_P"V/_L]>CT@"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`^<:***8!1
M110`4444`>U^`O\`D2]/_P"VG_HQJZ.N<\!?\B7I_P#VT_\`1C5T=(`HHHH`
M****`,?Q7?OIOA?4+J+=Y@CV*5;:5+$*&!]1NS^%>$UZS\3KCR_#L$*S;6EN
M5S&&P74*Q/'<`[?QQ7DU,`HHHH`****`'1QO-*D42,\CL%55&2Q/0`=S7O\`
MI&FQ:/I-MI\)RL*8+<_,W5FP2<9))QVS7DWP_L?MOBV!RL;);(TS!QGH-HQ[
MAF4_A7LU(`HHHH`****`"BBB@`HHHH`****`"J&N::-7T2\L"%+31D)N)`#C
ME2<<X#`&K]%`'SC16[XRM4L_%^I11EBK2"4[CSEU#G\,L:PJ8!1110`4444`
M>_Z'>&_T&PNGE6626!&D=<8+X^;IP#G/':K]<G\.;O[3X2CBV;?LTSQ9SG=D
M[\^WW\?A764@"BBB@`HHHH`;)&DT3Q2HKQNI5E89#`]01W%<O=?#S0+F^%R(
MIH5W;FAB?$;'.3QC(!Z84CCIBNJHH`S=+T#2M&W'3[*.%FSE^68@XXW')QP.
M,XK2HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"O*_B9I+6^K0ZG'
M'^ZN4"2,,G]XOKV&5QCUVFO5*Y?X@6/VWPE.X61GMG690@ST.TY]@K,?PH`\
M9HHHI@%%%%`!4EO<2VES%<0MMEB<.C8!PP.0<'WJ.B@#Z,CD2:))8G5XW4,K
M*<A@>A![BG5E^&Y$E\,:6T;JZBUC4E3D9"@$?4$$?A6I2`****`"BBB@#YQH
MHHI@%%%%`!1110`445/9V=Q?W<5K:Q-+/*VU$7J3_0>_:@`L[.XO[N*UM8FE
MGE;:B+U)_H/?M7LWA7PK;^'+3<VV6_E7]],!P!_=7T7^?4]@#PKX5M_#EIN;
M;+?RK^^F`X`_NKZ+_/J>P'0T@"BBB@`HHHH`****`"BBB@`HHHH`*\F^(^A_
M8=674H8\6]Y]_:.%E'7H,#<.>N2=QKUFL?Q3I)UKP[=6<:J9]H>'*@G>O(`S
MC!/*Y_VC0!X31113`****`"BBB@#UGX9W_VCP_-9M+N>UF.U-N-J-R.<<Y;?
M[_I7:UY?\++O9J>H6>S/FPK+OSTV'&,>^_\`2O4*0!1110`4444`%-DD2&)Y
M975(T4LS,<!0.I)["G5R?Q#U/[#X9>W1\2WCB(8DVL%ZL<=Q@!3_`+WX$`\H
MU2_?5-4NKZ3<&GD9PK-N*@GA<^@&!^%5***8!1110`4444`%>T>#?#":!IJR
MSQ+_`&E,O[YMV[:,\(#V'3..I[D`5Q'P^\/MJ>K#49ABULG##(/SR=5`(]#@
MG\!CFO7:0!1110`4444`%%%%`!1110`4444`%07EG;W]I+:W42RP2KM=&Z$?
MT/OVJ>B@#Q+Q5X5N/#EWN7=+82M^YF(Y!_NMZ-_/J.X'/5]#WEG;W]I+:W42
MRP2KM=&Z$?T/OVKQGQ5X5N/#EWN7=+82M^YF(Y!_NMZ-_/J.X#`YZBBB@`HH
MHH`****`"O:_`7_(EZ?_`-M/_1C5XI7M?@+_`)$O3_\`MI_Z,:@#HZ***0!1
M110`4444`%%%%`!1110`4444`%%%%`'SC1113`****`"BBB@#T?X4_\`,7_[
M8_\`L]>CUYQ\*?\`F+_]L?\`V>O1Z0!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`?.-%%%,`HHHH`****`/:_`7_(EZ?_VT
M_P#1C5T=<YX"_P"1+T__`+:?^C&KHZ0!1110`4444`><?%;_`)A'_;;_`-DK
MSBNZ^*-Q*VN6=N6_=1VV]5P.&9B"<_15_*N%I@%%%%`!1110!Z+\*HT,NJRE
M%,BK$JMCD`[\@'T.!^0KTFN*^&'_`"+5S_U^-_Z`E=K2`****`"BBB@`HHHH
M`****`"BBB@`HHHH`\I^*$;CQ!:RE&$;6H56QP2';(!]1D?F*X>O1_BM_P`P
MC_MM_P"R5YQ3`****`"BBB@#U3X77$3:'>6X;]['<[V7!X5E`!S]5;\J[JO.
M/A3_`,Q?_MC_`.SUZ/2`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`JMJ%I]OTRZL]^S[1"\6_&=NX$9QWZU9HH`^<:*GO+
M5[&^N+24J9()&B8J>"5.#CVXJ"F`4444`%%%%`'M?@+_`)$O3_\`MI_Z,:NC
MKF?`$B/X,LE1U9D:17`.2IWL<'T."#^(KIJ0!1110`4444`?.-%%%,`HHHH`
M****`'1QO-*D42,\CL%55&2Q/0`=S7M/A'PO!X?T]9)$SJ$R`SNV,IWV#'8'
M\R,^@&)\-_#\4-E_;<PCDEFRMOP<Q*"58_4D8^@Z\D5WU(`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`\'\3V/\`9WB;4+8+&JB8NBQC"JK?,H`[8!`K
M)KN/B?9F+7K:Z$2K'/!M+C&7=2<Y[Y`*<GV]*X>F`4444`%%%%`'4?#ZXEA\
M8VL<;869)$D&!RNTMC\U!_"O9J\)\*73V?BO3)8PI9IUB.X<8?Y#^.&->[4@
M"BBB@`HHHH`*\I^)NI"YUNWL$*E;2/+<$$.^"0>Q&T(>/4_AZM7@?B"__M3Q
M!?7@E\U))F\M]NW*#A>,#^$#WH`S:***8!1110`445M^$M,_M;Q-96[)NB5_
M-ES'O7:O.&'H2`O/][\*`/6/"FB_V%X?@M7&+A_WL_/\9ZCJ1P`!QP<9[UMT
M44@"BBB@`HHHH`****`"BBB@`HHHH`****`"H+RSM[^TEM;J)98)5VNC="/Z
M'W[5/10!X9XH\/R^'=6>WQ(UJ_S6\K@?.O<<=P3@].QP,BL2O?\`6M)M];TN
M:QN%7#J=CE<F-\<,.G(^O/(Z&O`*8!1110`4444`%>U^`O\`D2]/_P"VG_HQ
MJ\4KVOP%_P`B7I__`&T_]&-0!T=%%%(`HHHH`****`"BBB@`HHHH`****`"B
MBB@#YQHHHI@%%%%`!1110!Z/\*?^8O\`]L?_`&>O1Z\X^%/_`#%_^V/_`+/7
MH](`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`/G&BBBF`4444`%%%%`'M?@+_D2]/\`^VG_`*,:NCKG/`7_`")>G_\`;3_T
M8U='2`****`"BBB@#RGXH1N/$%K*481M:A5;'!(=L@'U&1^8KAZ]'^*W_,(_
M[;?^R5YQ3`****`"BBB@#UGX8?\`(M7/_7XW_H"5VM>;?"J1!+JL1=1(RQ,J
MYY(&_)`]!D?F*])I`%%%%`!1110`4444`%%%%`!1110`4444`>7_`!3N]^IZ
M?9[,>5"TN_/7><8Q[;/UK@:ZKXB73W'B^>)PH6WCCB3`Y(*[^??+G]*Y6F`4
M444`%%%%`'IGPKMY5MM3N"O[J1XXU;(Y90Q(Q]&7\Z]"KBOAA_R+5S_U^-_Z
M`E=K2`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`\#\0_\C+JO_7Y-_P"AFLVM+Q#_`,C+JO\`U^3?^AFLVF`4444`
M%%%%`'K/PP_Y%JY_Z_&_]`2NUKBOAA_R+5S_`-?C?^@)7:T@"BBB@`HHHH`^
M<:***8!1110`4444`>U^`O\`D2]/_P"VG_HQJZ.N<\!?\B7I_P#VT_\`1C5T
M=(`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`\_\`BG:N]CIUV"OEQ2/$
MPSSE@",>WR']*\QKUGXG_P#(M6W_`%^+_P"@/7DU,`HHHH`****`-+P]_P`C
M+I7_`%^0_P#H8KWROGK3[O[!J=K>;-_V>9)=F<;MI!QGMTKZ%I`%%%%`!111
M0!4U6Z>QTB]NX@ID@@DE4,."54D9]N*^?*]K\>7'V?P=?8F\IY-D:X;:6RPR
MH]<KNR/3->*4P"BBB@`HHHH`*]'^%EA_R$-1>+^[!')N_P"!.,9_W.<?3O7G
M%>R?#NU2W\(02H6+7$DDKY/`(;9Q[80?K0!U5%%%(`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`*^<:^CJ^<:`"BBBF`4444`%>U^`O^1+T__MI_Z,:O
M%*]K\!?\B7I__;3_`-&-0!T=%%%(`HHHH`****`"BBB@`HHHH`****`"BBB@
M#YQHHHI@%%%%`!1110!Z/\*?^8O_`-L?_9Z]'KSCX4_\Q?\`[8_^SUZ/2`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#YQH
MHHI@%%%%`!1110![7X"_Y$O3_P#MI_Z,:NCKG/`7_(EZ?_VT_P#1C5T=(`HH
MHH`****`.*^)UOYGAV"98=S17*YD"Y**58'GL"=OXXKR:O>/$]C_`&CX9U"V
M"R,QA+HL8RS,OS*`.^2`*\'I@%%%%`!1110!TW@+4AIWBNW#E1'=*;=B0206
MP5QCN6"C\3]:]HKYSCD>&5)8G9)$8,K*<%2.A![&O>/#VL)KNB6]\NT2,NV9
M5_AD'WAC)P.XSS@BD!J4444`%%%%`!1110`4444`%%%%`!4=Q<16EM+<3MMB
MB0N[8)PH&2<#VJ2N*^(^N?8=)7387Q<7GW]IY6(=>AR-QXZ8(W"@#RV\NGOK
MZXNY0HDGD:5@HX!8Y./;FH***8!1110`445);V\MW<Q6\*[I97$:+D#+$X`R
M?>@#VOP3;RVW@[3HYEVL4:0#(/RLQ93QZ@@UOU';V\5I;16\"[8HD$:+DG"@
M8`R?:I*0!1110`4444`%%%%`!1110`4444`%%%%`!152ZU73K&417=_:V\A7
M<%EF5"1ZX)Z<&L"Z^(GAZWB#Q7$URQ;&R*%@0/7YMHQ^/>@#JJ*\_NOBG:I*
M!::7-+'MY:641G/I@!N.G.:S;KXI:B\H-II]K%'MY64M(<^N05XZ<8H`]2HK
MR23XFZX\3HL-C&S*0'6-LJ?498C/U!JA_P`)[XE_Z"7_`)`C_P#B:`/:J*\5
M_P"$]\2_]!+_`,@1_P#Q-'_">^)?^@E_Y`C_`/B:`/:J*\5_X3WQ+_T$O_($
M?_Q-'_">^)?^@E_Y`C_^)H`]JHKQ7_A/?$O_`$$O_($?_P`31_PGOB7_`*"7
M_D"/_P")H`S?$/\`R,NJ_P#7Y-_Z&:S:DN+B6[N9;B9MTLKEW;`&6)R3@>]1
MTP"BBB@`HHHH`]9^&'_(M7/_`%^-_P"@)7:UQ7PP_P"1:N?^OQO_`$!*[6D`
M4444`%%%%`'SC1113`****`"BBB@#VOP%_R)>G_]M/\`T8U='7.>`O\`D2]/
M_P"VG_HQJZ.D`4444`%%%%`!1110`4444`%%%%`!1110`4444`<G\1K3[3X2
MDEW[?LTR2XQG=D[,>WW\_A7CM>U^/?\`D2]0_P"V?_HQ:\4I@%%%%`!1110`
M5]'5\XU]'4@"BBB@`HHHH`XCXH2(/#]K$742-=!E7/)`1LD#T&1^8KRBO1_B
MM_S"/^VW_LE><4P"BBB@`HHHH`*]_P!"C>'P_IL4J,DB6L2LK#!4A!D$=C7@
M%?1U(`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OG&OHZOG&@`
MHHHI@%%%%`!7M?@+_D2]/_[:?^C&KQ2O:_`7_(EZ?_VT_P#1C4`='1112`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`^<:***8!1110`4444`>C_"G_F+_P#;
M'_V>O1Z\X^%/_,7_`.V/_L]>CT@"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`^<:***8!1110`4444`>U^`O^1+T_\`[:?^
MC&KHZYSP%_R)>G_]M/\`T8U='2`****`"BBB@`KPSQ7HO]A>()[5!BW?][!S
M_`>@ZD\$$<\G&>]>YUQWQ!\/KJ>DG481BZLD+'`'SQ]6!)]!DC\1CF@#R*BB
MBF`4444`%=1X+\4?\(_J#173R'3Y^'4<B-N,/CZ<'';UP!7+T4`?1D<B31)+
M$ZO&ZAE93D,#T(/<4ZO(/!OC)]#E6RO69]-=N#U,!/<>J^H_$<Y!]8L[RWO[
M2*ZM95E@E7<CKT(_H?;M2`GHHHH`****`"BBB@`HHK-UG7=/T&V$U_-LWY$<
M:C+2$#.`/ZG`Y&2,T`2ZMJUIHNGR7M[)LB7@`<L[=E4=R?\`Z_05X=K6KW&M
MZI-?7#-EV.Q"V1&F>%'3@?3GD]34WB#Q!=^(M0-Q<'9&N1#"#E8U_J3W/?Z`
M`9-,`HHHH`****`"NL^'FF?;O$R7#IF*S0RG,>Y2W11GL<DL/]W\1R=>U^"=
M#_L7P_'YL>V[N<2S9&"N?NJ>`>!V/0EJ`.CHHHI`%%%%`!1110`4444`%%%8
M'B#Q=IOA]"DC^?=G(%O$PW`XR-W]T<CWYX!H`WZPM6\7Z+HZL)KM9IE8J8+<
MAW!!`(/.%(SW(Z&O,M<\;:OK6^+S?LMHV1Y,)QN'/#-U;@X(X!QTKFZ`.^U/
MXGW<NZ/3+..!?F`EF.]L?PL`,`'O@[A_7E[[Q/K>H[A<ZG<%638R(WEJR\Y!
M5<`]>XK)HI@%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>
ML_##_D6KG_K\;_T!*[6N*^&'_(M7/_7XW_H"5VM(`HHHH`****`/G&BBBF`4
M444`%%%%`'M?@+_D2]/_`.VG_HQJZ.N<\!?\B7I__;3_`-&-71T@"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@#G/'O\`R)>H?]L__1BUXI7M?CW_`)$O
M4/\`MG_Z,6O%*8!1110`4444`%?1U?.-?1U(`HHHH`****`/+?BE=.^KV-H0
MOEQ0&53CG+,0<^WR#]:X.NU^)_\`R,MM_P!>:_\`H;UQ5,`HHHH`****`-+P
M]_R,NE?]?D/_`*&*]\KP/P]_R,NE?]?D/_H8KWRD`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!7SC7T=7SC0`4444P"BBB@`KVOP%_R)>G_P#;
M3_T8U>*5[7X"_P"1+T__`+:?^C&H`Z.BBBD`4444`%%%%`!1110`4444`%%%
M%`!1110!\XT444P"BBB@`HHHH`]'^%/_`#%_^V/_`+/7H]><?"G_`)B__;'_
M`-GKT>D`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`'SC1113`****`"BBB@#VOP%_R)>G_]M/\`T8U='7.>`O\`D2]/_P"V
MG_HQJZ.D`4444`%%%%`!1110!XOXR\,/H&I-+!$W]FS-^Y;=NVG'*$]CUQGJ
M.Y(-<S7JGQ#U_3XM/?2##'=7DF&P>EOZ-D?Q8Z#T//!P?*Z8!1110`4444`%
M7=-U?4-'G,VGW<D#'[P4Y5N".5/!ZGJ.*I44`>DZ;\4D*A=4T]@P4YDM3D$Y
MX&UCP,=]QZ>_'56GB_P_>[_*U6W79C/G$Q=?3?C/3M7AE%`'T5;W$%W`LUO-
M'-$V=LD;!E.#C@CWJ2OG&BD!]#W5Y:V,0EN[F&WC+;0TL@0$^F3WX-8]]XU\
M/V&X/J,<SA-X6W!DW=>,CY0>.Y%>(44P/0-6^)]Q(S1Z3:K%&5(\VX&Y\D#D
M*#@$'/7=GCZ5P=Q<3W<[37$TDTK8W22,68X&.2?:HZ*`"BBB@`HHHH`***NZ
M3I-WK6H1V5E'OD;DD\*B]V8]@/\`ZW4T`;O@?PV=;U07-Q&WV"V8,Q*@K(X(
M(3GJ.YX/''&0:]DJEI.DVFBZ?'964>R)>23RSMW9CW)_^MT%7:0!1110`444
M4`%%%%`!39)$AB>65U2-%+,S'`4#J2>PHDD2&)Y975(T4LS,<!0.I)["O(O&
M7C)]<E:RLF9--1N3T,Y'<^B^@_$\X``-3Q1\0VEWV>AOB)DP]V5*MD_W,XQQ
MD9(SSQC`)\\HHI@%%%%`!1110`4444`%%%%`!16A'H6KS1)+%I5\\;J&5EMW
M(8'H0<<BK=IX0\07N_RM*N%V8SYP$77TWXST[4`8E%=)_P`(%XE_Z!O_`)'C
M_P#BJ/\`A`O$O_0-_P#(\?\`\50!S=%=)_P@7B7_`*!O_D>/_P"*H_X0+Q+_
M`-`W_P`CQ_\`Q5`'-T5TG_"!>)?^@;_Y'C_^*H_X0+Q+_P!`W_R/'_\`%4`<
MW14EQ;RVES+;S+MEB<QNN0<,#@C(]ZCH`****`"BBB@#UGX8?\BU<_\`7XW_
M`*`E=K7%?##_`)%JY_Z_&_\`0$KM:0!1110`4444`?.-%%%,`HHHH`****`/
M:_`7_(EZ?_VT_P#1C5T=<YX"_P"1+T__`+:?^C&KHZ0!1110`4444`%%%%`!
M1110`4444`%%%%`!1110!SGCW_D2]0_[9_\`HQ:\4KVOQ[_R)>H?]L__`$8M
M>*4P"BBB@`HHHH`*^CJ^<:^CJ0!1110`4444`>3?$_\`Y&6V_P"O-?\`T-ZX
MJNU^)_\`R,MM_P!>:_\`H;UQ5,`HHHH`****`-+P]_R,NE?]?D/_`*&*]\KP
M/P]_R,NE?]?D/_H8KWRD`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!7SC7T=7SC0`4444P"BBB@`KVOP%_R)>G_P#;3_T8U>*5[7X"_P"1+T__
M`+:?^C&H`Z.BBBD`4444`%%%%`!1110`4444`%%%%`!1110!\XT444P"BBB@
M`HHHH`]'^%/_`#%_^V/_`+/7H]><?"G_`)B__;'_`-GKT>D`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'SC1113`****`"
MBBB@#VOP%_R)>G_]M/\`T8U='7.>`O\`D2]/_P"VG_HQJZ.D`4444`%%%%`!
M6%XJ\1IX<TOSPBR7,K;((R<`G'+$==H[X]0.,YK;DD2&)Y975(T4LS,<!0.I
M)["O"?$FMRZ_K,MX_$8^2!=H!6,$X!Z\\DGGJ?3%`&;<7$MW<RW$S;I97+NV
M`,L3DG`]ZCHHI@%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445
MU'AOP3J&M3Q37$4EKIY^9IF&&<8!P@/7(/#8QUZXP0#$TG2;O6M0CLK*/?(W
M))X5%[LQ[`?_`%NIKVOP_P"'[3P[IXM[<;Y6P9IB,-(W]`.P[?4DFSI.DVFB
MZ?'964>R)>23RSMW9CW)_P#K=!5VD`4444`%%%%`!1110`445E^(=830M$N+
MYMID5=L*M_%(?NC&1D=SCG`-`''?$3Q.\3'1+*5D8K_I;!<'!`(0'T(.3]0,
M]17FU.DD>:5Y979Y'8LS,<EB>I)[FFTP"BBB@`HHHH`**='&\TJ11(SR.P55
M49+$]`!W->C^&_APGE?:->5O,W';:I)P!R,LR]3W`![<YS@`'#:;H>IZNP%A
M8S3*6*[PN$!`S@L>`<>I[BNUTWX6N6#:IJ"A0QS':C)(QP=S#@Y[;3T]^/1X
MXTAB2*)%2-%"JJC`4#H`.PIU(#`L?!7A^PVE-.CF<)L+7!,F[IS@_*#QV`K;
MM[>"T@6&WACAB7.V.-0JC)SP![U)10`4444`%%%%`!1110`4444`>!^(?^1E
MU7_K\F_]#-9M:7B'_D9=5_Z_)O\`T,UFTP"BBB@`HHHH`]9^&'_(M7/_`%^-
M_P"@)7:UQ7PP_P"1:N?^OQO_`$!*[6D`4444`%%%%`'SC1113`****`"BBB@
M#VOP%_R)>G_]M/\`T8U='7.>`O\`D2]/_P"VG_HQJZ.D`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`<YX]_Y$O4/^V?_`*,6O%*]K\>_\B7J'_;/_P!&
M+7BE,`HHHH`****`"OHZOG&OHZD`4444`%%%%`'E?Q1MY5URSN"O[J2V\M6R
M.65B2,?1E_.N%KT?XK?\PC_MM_[)7G%,`HHHH`****`)+>XEM+F*XA;;+$X=
M&P#A@<@X/O7T57SC7T+I]W]OTRUO-FS[1"DNS.=NX`XSWZT@+-%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`5\XU]'5\XT`%%%%,`HHHH`*]K\!?
M\B7I_P#VT_\`1C5XI7M?@+_D2]/_`.VG_HQJ`.CHHHI`%%%%`!1110`4444`
M%%%%`!1110`4444`?.-%%%,`HHHH`****`/1_A3_`,Q?_MC_`.SUZ/7G'PI_
MYB__`&Q_]GKT>D`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`'SC1113`****`"BBB@#VOP%_P`B7I__`&T_]&-71USG@+_D
M2]/_`.VG_HQJZ.D`4444`%%%%`'`_$S6O(LH='B/SW&)9N.B`_*.G=AG@Y&W
MWKR^M;Q+JS:SX@N[OS-\6\I#C(`C'"X!Z9')]R:R:8!1110`445UGP^T7^U/
M$`NI!FWL<2GGJ_\``.H/4$]Q\N#UH`Z_P=X,M]/TTW.HPK/<W<8WPRIE8TR&
M"E3U;(!.1P1@=,G+USX9_?GT6?U/V:8_4X5OR`!_%J]'HI`?/5]I]WIERUO>
MV\D$H_A<8R,D9![C(/(XJM7T5<6\%W`T-Q#'-$V-T<BAE.#GD'WKF;_X>:!>
MR^8D4UHQ8LPMWP&)]F!``[`8ZTP/&Z*[Z[^%EZFS['J5O-G._P`Y&CQZ8QNS
MW]*QY/`'B1)71;!9%5B`ZSIAAZC)!Q]0*`.9HK6N/"^NVT[0R:3>%EQDQQ&1
M>F>&7(/YU'_PCVM_]`?4/_`9_P#"@#-HK6M_"^NW,ZPQZ3>!FS@R1&->F>6;
M`'YU>_X0+Q+_`-`W_P`CQ_\`Q5`'-T5W5O\`"[5&G47%]9QQ<[FCW.PX[`@9
MY]ZVK'X8:;#M:]O+BY8/G"`1J5X^4CD^O((ZT`>5UOZ3X,UO5TCEAM?)MWZ3
M3G8N,9!`^\0<C!`(KUO3?#FCZ2P>RT^&.0,6$A&]P2,'#-D@8[9]?6M2D!R>
MB_#[2-+Q)=+]ON!_%,OR#KT3D=".N>1D8KK***`"BBB@`HHHH`****`"BBB@
M`KROXF:LUQJT.F1R?NK9`\BC(_>-Z]CA<8]-QKU2OG[6+[^T]9O+T-(5FF9T
M\P_,%S\H/T&!^%`%*BBBF`4444`%%%=1X#T2+6/$`-S%YEK;(975D)5FZ*I/
MUYP>NTC'6@#L_`WA--*M(]2O86&HRJ=JR#!@4]@/[Q'4]1G''.>SHHI`%%%%
M`!1110`4444`%%%%`!1110`4444`>!^(?^1EU7_K\F_]#-9M:7B'_D9=5_Z_
M)O\`T,UFTP"BBB@`HHHH`]9^&'_(M7/_`%^-_P"@)7:UQ7PP_P"1:N?^OQO_
M`$!*[6D`4444`%%%%`'SC1113`****`"BBB@#VOP%_R)>G_]M/\`T8U='7.>
M`O\`D2]/_P"VG_HQJZ.D`4444`%%%%`!1110`4444`%%%%`!1110`4444`<Y
MX]_Y$O4/^V?_`*,6O%*]K\>_\B7J'_;/_P!&+7BE,`HHHH`****`"OHZOG&O
MHZD`4444`%%%%`'"_%&WB;0[.X*_O8[GRU;)X5E)(Q]57\J\KKV;X@V\4W@Z
MZDD7+0O')&<GAMP7/Y,1^->,TP"BBB@`HHHH`*]S\(7?VWPEILNS9MA$6,Y^
MX2F?QVY_&O#*];^&=X9_#<EN\JLUO.RJG&40@,,]\%B_)]_2@#LZ***0!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`5\XU]'5\XT`%%%%,`HHHH`*]K\
M!?\`(EZ?_P!M/_1C5XI7M?@+_D2]/_[:?^C&H`Z.BBBD`4444`%%%%`!1110
M`4444`%%%%`!1110!\XT444P"BBB@`HHHH`]'^%/_,7_`.V/_L]>CUYQ\*?^
M8O\`]L?_`&>O1Z0!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`?.-%%%,`HHHH`****`/:_`7_(EZ?\`]M/_`$8U='7.>`O^
M1+T__MI_Z,:NCI`%%%%`!5#7+PV&@W]TDJQ210.T;MC`?'R]>"<XX[U?KG/'
MO_(EZA_VS_\`1BT`>*4444P"BBB@`KUOX9V9@\-R7#Q*K7$[,K\9=``HSWP&
M#\'W]:\DKVCP!(C^#+)4=69&D5P#DJ=['!]#@@_B*`.FHHHI`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!0UV1X?#^I2Q.
MR2):RLK*<%2$."#V->`5[7X]_P"1+U#_`+9_^C%KQ2F`4444`%%%%`!7KOPV
ML?LWADW++'NNIF<,H^;:OR@$^Q#'\?>O(J]V\*6J6?A33(HRQ5H%E.X\Y?YS
M^&6-`&Q1112`****`"BBB@`HHHH`****`"BBB@`HHHH`\#\0_P#(RZK_`-?D
MW_H9K-K2\0_\C+JO_7Y-_P"AFLVF`4444`%%%%`'K/PP_P"1:N?^OQO_`$!*
M[6N*^&'_`"+5S_U^-_Z`E=K2`****`"BBB@#YQHHHI@%%%%`!1110![7X"_Y
M$O3_`/MI_P"C&KHZYSP%_P`B7I__`&T_]&-71T@"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@#G/'O_(EZA_VS_\`1BUXI7M?CW_D2]0_[9_^C%KQ2F`4
M444`%%%%`!7T=7SC7T=2`****`"BBB@"EK-O+=Z'J%O"NZ66VDC1<@98J0!D
M^]?/U?1U?/VL6/\`9FLWED%D"PS,B>8/F*Y^4GZC!_&@"E1113`****`"NZ^
M&%]Y.LW=DS1JMQ"'&XX8LAX`_!F/X>U<+6AH>I'2-;L[\%@L,@+[0"2AX8#/
M&2I(H`]^HIL<B31)+$ZO&ZAE93D,#T(/<4ZD`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`07EY;V%I+=74JQ01+N=VZ`?U/MWKYXKL?&WBZ75[F33K1]
MNGQ.0Q5@?/8'[V1_#GH/Q],<=3`****`"BBB@`KVOP%_R)>G_P#;3_T8U>*5
M[7X"_P"1+T__`+:?^C&H`Z.BBBD`4444`%%%%`!1110`4444`%%%%`!1110!
M\XT444P"BBB@`HHHH`]'^%/_`#%_^V/_`+/7H]><?"G_`)B__;'_`-GKT>D`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'S
MC1113`****`"BBB@#VOP%_R)>G_]M/\`T8U='7.>`O\`D2]/_P"VG_HQJZ.D
M`4444`%<=\2_/_X19/*\S9]I3S=F<;<-][VW;>O?%=C7/>.8WE\&:BL:,[!4
M8A1DX#J2?H`"?PH`\2HHHI@%%%%`!7>?#;7DL[N72;F14BN6#P%C@>9P"O3J
MPQU/\.!R:X.B@#Z.HKS;PQ\1!%%%9:V6*HI`O.6.!T#@#)/4;A[9'4UZ%:WE
MK?1&6TN8;B,-M+12!P#Z9'?D4@)Z***`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@#G/'O\`R)>H?]L__1BUXI7M_C:WEN?!VHQP
MKN8(LA&0/E5@S'GT`)KQ"F`4444`%%%%`!7O'A>XBN?"VER0MN46R(3@CYE&
MUASZ$$5X/7LGP[NDN/"$$2!@UO))$^1P26W\>V''ZT`=51112`****`"BBB@
M`HHHH`****`"BBB@`ILDB0Q/+*ZI&BEF9C@*!U)/84ZO*_'GBZ+4\Z5I[[K6
M-P99E8XE8?PCU4'G/<@8Z9(!R6LW$5WKFH7$#;HI;F1T;!&5+$@X/M5*BBF`
M4444`%%%%`'K/PP_Y%JY_P"OQO\`T!*[6N*^&'_(M7/_`%^-_P"@)7:T@"BB
MB@`HHHH`^<:***8!1110`4444`>U^`O^1+T__MI_Z,:NCKG/`7_(EZ?_`-M/
M_1C5T=(`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`YSQ[_R)>H?]L_\`
MT8M>*5[7X]_Y$O4/^V?_`*,6O%*8!1110`4444`%?1U?.-?1U(`HHHH`****
M`"O(OB38_9O$PN563;=0JY9A\NY?E(!]@%/X^]>NUQGQ*TT77AU+T!?,LY`2
M23G8V%(`Z$YV'GT/X@'DE%%%,`HHHH`****`/8OA]K7]J>'Q:R'-Q8XB/'5/
MX#T`Z`CN?ER>M=97AGA36O["\0073G%N_P"ZGX_@/4]">"`>.3C'>O<8Y$FB
M26)U>-U#*RG(8'H0>XI`.HHHH`****`"BBB@`HHHH`****`"BBB@`KS'QUXR
M>:6?1=.9DB1C'<R]"Y'!0>B]B>_3IUT/&WC;['YFE:5+_I/*SW"G_5>JJ?[W
MJ>WUZ>7T`%%%%,`HHHH`****`"O:_`7_`")>G_\`;3_T8U>*5[7X"_Y$O3_^
MVG_HQJ`.CHHHI`%%%%`!1110`4444`%%%%`!1110`4444`?.-%%%,`HHHH`*
M***`/1_A3_S%_P#MC_[/7H]><?"G_F+_`/;'_P!GKT>D`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'SC1113`****`"BBB
M@#VOP%_R)>G_`/;3_P!&-71USG@+_D2]/_[:?^C&KHZ0!1110`5!>6J7UC<6
MDI81SQM$Q4\@,,''OS4]%`'SQ>6KV-]<6DI4R02-$Q4\$J<''MQ4%>A_$GP^
MR3C78!E'VQW"@$D-C`?/0#`"]N<=<UYY3`****`"BBB@`J2WN)[2=9K>:2&5
M<[9(V*L,C'!'M4=%`&_;^-O$=M`L,>J2%5S@R(LC=<\LP)/YUK?\+/UO_GUT
M_P#[]O\`_%UQ5%`'H=O\5)U@47&DQR2\[FCG**>>P(../>I/^%K?]07_`,FO
M_L*\XHH`]'_X6M_U!?\`R:_^PJ[;_%'2V@4W%C>1R\[ECVNHY[$D9X]J\KHH
M`]9_X6?HO_/KJ'_?M/\`XNC_`(6?HO\`SZZA_P!^T_\`BZ\FHH`]FM_B#X<F
M@622[D@8YS')"Q8<]]H(_6I?^$]\-?\`02_\@2?_`!->*44`>U_\)[X:_P"@
ME_Y`D_\`B:OQ^)-#EB21=7L0KJ&`:=5.#Z@G(/L:\%HH`^A[6\M;Z(RVES#<
M1AMI:*0.`?3([\BIZ^<:T+/7-5L%B2UU&ZBCB;<D:RG8#G/W>A&>V.:0'OU%
M>16/Q)UNVVK<BWNUWY8NFQMO&5!7`'U(/7O75:;\2M'NE`O4FLI-I))7S$SG
M@`KR3CG[H[_B`=G14=O<07<"S6\T<T39VR1L&4X.."/>I*`"BBB@`HHHH`J:
MK:O?:1>VD1423P21*6/`+*0,^W-?/E?1U>!^(+#^R_$%]9B+RDCF;RTW;L(>
M5YR?X2/>@#-HHHI@%%%%`!79_#C6$L-;DL9MJQWRA58\8D7.T9)Z')'<D[:X
MRG1R/#*DL3LDB,&5E."I'0@]C0!]&45@>%/$T7B33V<IY5W!@3Q@';DYPRGT
M.#QU&/H3OT@"BBB@`HHHH`****`"BBB@`ILDB0Q/+*ZI&BEF9C@*!U)/856U
M+4[+2+0W5_<+#"&"[B"22>P`Y)^GH:\D\4>-+OQ!OM8E^SZ>'RL8^](!TWG/
MKS@<?7`-`&AXL\>OJD4NG:8&BM"Q5Y\X:9?0#^%3S[D8Z<BN'HHI@%%%%`!1
M110`4444`>L_##_D6KG_`*_&_P#0$KM:XKX8?\BU<_\`7XW_`*`E=K2`****
M`"BBB@#YQHHHI@%%%%`!1110![7X"_Y$O3_^VG_HQJZ.N<\!?\B7I_\`VT_]
M&-71T@"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#G/'O_(EZA_VS_P#1
MBUXI7M?CW_D2]0_[9_\`HQ:\4I@%%%%`!1110`5]'5\XU]'4@"BBB@`HHHH`
M*@O+5+ZQN+24L(YXVB8J>0&&#CWYJ>B@#YXO+5[&^N+24J9()&B8J>"5.#CV
MXJ"N^^)FB^1>PZQ$/DN,13<]'`^4]>ZC'`P-OO7`TP"BBB@`HHHH`*])^'_B
MQ/*31=0F;S-V+61SP1VCSV/IGUQQ@`^;44`?1U%<1X3\>IJDL6G:F%BNRH5)
M\X69O0C^%CQ[$YZ<"NWI`%%%%`!1110`4444`%%%4-6UJPT2T:XOIU0;24C!
M&^0C'"CN>1],\X%`%V21(8GEE=4C12S,QP%`ZDGL*\Q\;>-OMGF:5I4O^C<K
M/<*?];ZJI_N^I[_3KD^*/&EWX@WVL2_9]/#Y6,?>D`Z;SGUYP./K@&N7I@%%
M%%`!1110`4444`%%%%`!7M?@+_D2]/\`^VG_`*,:O%*]K\!?\B7I_P#VT_\`
M1C4`='1112`****`"BBB@`HHHH`****`"BBB@`HHHH`^<:***8!1110`4444
M`:6DZ]J>A^=_9USY/G;?,_=JV<9Q]X'U-:7_``GOB7_H)?\`D"/_`.)KFZ*`
M.D_X3WQ+_P!!+_R!'_\`$T?\)[XE_P"@E_Y`C_\`B:YNB@#I/^$]\2_]!+_R
M!'_\31_PGOB7_H)?^0(__B:YNB@#I/\`A/?$O_02_P#($?\`\31_PGOB7_H)
M?^0(_P#XFN;HH`Z3_A/?$O\`T$O_`"!'_P#$T?\`">^)?^@E_P"0(_\`XFN;
MHH`Z3_A/?$O_`$$O_($?_P`31_PGOB7_`*"7_D"/_P")KFZ*`.D_X3WQ+_T$
MO_($?_Q-'_">^)?^@E_Y`C_^)KFZ*`.D_P"$]\2_]!+_`,@1_P#Q-'_">^)?
M^@E_Y`C_`/B:YNB@#I/^$]\2_P#02_\`($?_`,31_P`)[XE_Z"7_`)`C_P#B
M:YNB@#V3P?XP'B-9+:YB6*_B4N1&#L=,XR,YP1D`@GW'<#JJ\'\+W$MMXITN
M2%MK&Y1"<`_*QVL.?4$BO>*0!1110`4444`?.-%%%,`HHHH`****`/:_`7_(
MEZ?_`-M/_1C5T=<YX"_Y$O3_`/MI_P"C&KHZ0!1110`4444`1W%O%=VTMO.N
MZ*5#&ZY(RI&",CVKQ;Q5X5N/#EWN7=+82M^YF(Y!_NMZ-_/J.X'MM-DC2:)X
MI45XW4JRL,A@>H([B@#YSHKT/Q!\-I4<SZ$?,0Y+6TK@,#G^%CP1@]SGCJ<U
MY])&\,KQ2HR2(Q5E88*D=01V-,!M%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`%FQU"[TRY6XLKB2"4?Q(<9&0<$=QD#@\5Z!X?^)0
M=DM]<14&W_CZC4XR`/O(,\GGD>HX`YKS:B@#Z*M[B"[@6:WFCFB;.V2-@RG!
MQP1[U)7AGA_Q1J'AV<?9WWVK.&EMV^Z_&.#_``G'<>@SG&*]FTG5K36M/CO;
M*3?$W!!X9&[JP[$?_7Z&D!=HHHH`*\T^)^DK'/::K%'CS<PS,,`%@,J<=22-
MPSZ*.E>EU2U?38M8TFYT^8X69,!N?E;JK8!&<$`X[XH`^?J*GO+.XL+N6UNH
MFBGB;:Z-U!_J/?O4%,`HHHH`****`+-CJ%WIERMQ97$D$H_B0XR,@X([C('!
MXKUOPUXXL-;5+>Y*VM_M`*.0$D8G'R$GD].#SSQG!->-T4`?1U%>(:3XSUO2
M$CBANO.MTZ0SC>N,8`!^\`,#`!`KK;'XIP-M74--D3"<O;N&W-Q_"<8'7N?Q
MZT@/0J*Y"U^)&@7$I24W5LH7.^6+()]/E+'/X=JN?\)[X:_Z"7_D"3_XF@#H
MZ*XK_A9^B_\`/KJ'_?M/_BZQ+OXIWK[/L>FV\.,[_.=I,^F,;<=_6@#TZ21(
M8GEE=4C12S,QP%`ZDGL*XS7/B/I]COATU/MMP,CS.D2GD=>K<@=."#]ZO.-4
MU_5=9VC4+V295QA.%4$9YVC`SR><9K-I@7=2U?4-8G$VH7<D[#[H8X5>`.%'
M`Z#H.:I444`%%%%`!13HXWE8K&C.P4L0HR<`9)^@`)_"FT`%%%%`!1110!ZS
M\,/^1:N?^OQO_0$KM:XKX8?\BU<_]?C?^@)7:T@"BBB@`HHHH`^<:***8!11
M10`4444`>U^`O^1+T_\`[:?^C&KHZYSP%_R)>G_]M/\`T8U='2`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`.<\>_P#(EZA_VS_]&+7BE>U^/?\`D2]0
M_P"V?_HQ:\4I@%%%%`!1110`5]'5\XU]'4@"BBB@`HHHH`****`*6KZ;%K&D
MW.GS'"S)@-S\K=5;`(S@@''?%>#ZA8SZ9J$]E<+B6%RC<'!]QGL1R/8U]"UP
M?Q$\-BZM#K-K&HG@7_2`JG=(G`#<=U_EW^4"@#RVBBBF`4444`%%%%`!79^'
M_B'?Z:J6^HJU];[O]8SGS5!([G[P'/!]>H`KC**`/=M)\4Z/K3+'9WB^>5!\
MF0;'S@G`!^\1@YQFMBOG&M"SUS5;!8DM=1NHHXFW)&LIV`YS]WH1GMCFD![]
M17BO_">^)?\`H)?^0(__`(FC_A/?$O\`T$O_`"!'_P#$T`>U50U+7-,TA2;^
M]AA8*&V%LN03C(4<D9]!V->*7GB36K]I3<:G=,LJ[719"J$8QC:,#&/;FLN@
M#T?7/B9]^#18/4?:9A]1E5_(@G\5K@;[4+O4[EKB]N))Y3_$YS@9)P!V&2>!
MQ5:BF`4444`%%%%`!3A&YB:4(QC5@K-C@$YP"?4X/Y&M3P_X?N_$6H"WMQLC
M7!FF(RL:_P!2>P[_`$!([;QUI-IHO@JSLK*/9$MXI)/+.VQ\LQ[D_P#UN@H`
M\SHHHH`****`"O:_`7_(EZ?_`-M/_1C5XI7M?@+_`)$O3_\`MI_Z,:@#HZ**
M*0!1110`4444`%%%%`!1110`4444`%%%%`'SC1113`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KZ.KYQKZ.I`%%%%`!11
M10!\XT444P"BBB@`HHHH`]K\!?\`(EZ?_P!M/_1C5T=<YX"_Y$O3_P#MI_Z,
M:NCI`%%%%`!1110`445Y?XV\;?;/,TK2I?\`1N5GN%/^M]54_P!WU/?Z=0"?
MQ9\0'\V73]%D7R]I22['4G_IF>PZC=[\8P"?.J**8!1110`444Z.-YI4BB1G
MD=@JJHR6)Z`#N:`&T5WUC\+KN:V62]U".VE//E)'YF!@=3D<YR.,CCK5G_A5
M/_4:_P#)7_[.@#SBBO1_^%4_]1K_`,E?_LZ/^%4_]1K_`,E?_LZ`/.**[7_A
M6&M_\_6G_P#?Q_\`XBC_`(5AK?\`S]:?_P!_'_\`B*`.*HKM?^%8:W_S]:?_
M`-_'_P#B*ANOAOK]O$'B%K<L6QLBEP0/7Y@HQ^/>@#D**Z3_`(0+Q+_T#?\`
MR/'_`/%4?\(%XE_Z!O\`Y'C_`/BJ`.;HK6N/"^NVT[0R:3>%EQDQQ&1>F>&7
M(/YUDT`%%%%`!1110`4444`%:WA_Q!=^'=0%Q;G?&V!-"3A9%_H1V/;Z$@Y-
M%`'T'IFI6^KZ;!?VI8PS+E=PP00<$'W!!%6Z\B^'WB!M,U8:=,<VMZX49)^2
M3HI`'J<`_@<\5Z[2`****`.%^(/A?[=;'5[-(UN+="UP.AD0#KGIE0#[D=^`
M*\KKZ.KR_P`;>"?L?F:KI47^C<M/;J/]5ZLH_N^H[?3H`<#1113`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"I[.SN+^[BM;6)I9Y6VHB]2?Z#W[5;T
M;0M0UZY,%A#OV8,DC'"Q@G&2?Z#)X.`<5[#X?\+Z?X=@'V=-]TR!9;AOO/SG
M@?PC/8>@SG&:`,>V\*V_ASP?JK-MEOY;*7SI@.`-A^5?1?Y]3V`\DKWSQ#_R
M+6J_]><W_H!KP.@`HHHH`****`/6?AA_R+5S_P!?C?\`H"5VM<5\,/\`D6KG
M_K\;_P!`2NUI`%%%%`!1110!\XT444P"BBB@`HHHH`]K\!?\B7I__;3_`-&-
M71USG@+_`)$O3_\`MI_Z,:NCI`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`'.>/?^1+U#_MG_P"C%KQ2O:_'O_(EZA_VS_\`1BUXI3`****`"BBB@`KZ
M.KYQKZ.I`%%%%`!1110`4444`%%%%`'DGCGPF^E7<FI64*C3I6&Y8Q@0,>Q'
M]TGH>@SCCC/&5]&21I-$\4J*\;J596&0P/4$=Q7DGB[P3/I$[7>G123:>V6*
MJ"S08&2#_LX_B_`^I8''4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!70^%?"MQXCN]S;HK")OWTP')/]U?5OY=3V!V?"_P^GOMEYJZR6]NK\6S*
M5>0#KGNHSCW(STX->I1QI#$D42*D:*%55&`H'0`=A0!!8Z?::9;+;V5O'!$/
MX4&,G`&2>YP!R>:Y/XG_`/(M6W_7XO\`Z`]=K7%?$_\`Y%JV_P"OQ?\`T!Z0
M'DU%%%,`HHHH`*]K\!?\B7I__;3_`-&-7BE>U^`O^1+T_P#[:?\`HQJ`.CHH
MHI`%%%%`!1110`4444`%%%%`!1110`4444`>!Z]I,NBZS<V4D<B(KDPF3!+Q
MY.ULC@Y'ZY':LVO<?$?A6P\1Q*9]T-S&I$<\8&0.>&'=<\X_(C)KR_4O!&OZ
M:QS9-<Q[@HDM?W@)(ST'S`=LD#^5,#GJ*TO^$>UO_H#ZA_X#/_A1_P`(]K?_
M`$!]0_\``9_\*`,VBM+_`(1[6_\`H#ZA_P"`S_X4?\(]K?\`T!]0_P#`9_\`
M"@#-HK2_X1[6_P#H#ZA_X#/_`(4?\(]K?_0'U#_P&?\`PH`S:*TO^$>UO_H#
MZA_X#/\`X4?\(]K?_0'U#_P&?_"@#-HK2_X1[6_^@/J'_@,_^%'_``CVM_\`
M0'U#_P`!G_PH`S:*TO\`A'M;_P"@/J'_`(#/_A1_PCVM_P#0'U#_`,!G_P`*
M`,VBM+_A'M;_`.@/J'_@,_\`A1_PCVM_]`?4/_`9_P#"@#-HK2_X1[6_^@/J
M'_@,_P#A1_PCVM_]`?4/_`9_\*`,VBM+_A'M;_Z`^H?^`S_X4?\`"/:W_P!`
M?4/_``&?_"@#-HK2_P"$>UO_`*`^H?\`@,_^%'_"/:W_`-`?4/\`P&?_``H`
MS:*TO^$>UO\`Z`^H?^`S_P"%'_"/:W_T!]0_\!G_`,*`#P_;_:_$6FPF'SE:
MYCWQ[=P*A@6R/3&<^U>^5Y_X"\(7%A<'5=3@:*95`MHR_(##YF8#H<'`!Z<Y
M'2O0*0!1110`4444`?.-%=5XH\%W^D7=Q<6MNTVFEBZ/'EC$O)PPR3@`?>Z=
M.<G%<K3`****`"BBM#3=#U/5V`L+&:92Q7>%P@(&<%CP#CU/<4`>M^`O^1+T
M_P#[:?\`HQJZ.LW0-+_L;0K33RVYHD^<YR"Q)9L<#C)./:M*D`4444`%%%<]
MXR\0'0-$:2!U%Y.WEP`@'![M@GH!]>2N1S0!R_Q`\6/YKZ+I\R^7MQ=2(>2>
M\>>P]<>N.,$'SJBBF`4444`%%%.CC>:5(HD9Y'8*JJ,EB>@`[F@"6SL[B_NX
MK6UB:6>5MJ(O4G^@]^U>O^%_!=IX?V74K?:-0*8:0_=C)Z[!CTXR>?IDBF^"
MO"I\/VCW%UM:_N%&\``B)?[H/<^O;@>F3U5(`HHHH`****`"BBB@`HHHH`**
M**`"H+JSM;Z(17=M#<1AMP66,.`?7![\FIZ*`.,U+X:Z/=*39/-92;0``WF)
MG/)(;DG''WAV_'S_`%KPIJ^A9>ZM]]N/^7B'YD[=3U7D@<@9/3->YTV2-)HG
MBE17C=2K*PR&!Z@CN*`/G.BN^\;>"?L?F:KI47^C<M/;J/\`5>K*/[OJ.WTZ
M<#3`****`"BBB@`KW;PMJYUKP[:WDC*9]I2;#`G>O!)QC!/#8_VA7A->A_"R
M^VW.H:>S2'>BS(,_*N#M;\3N7\O84`>ET444@"BBB@#A?%'P^@OM]YI"QV]P
MJ<VRJ%20CICLIQGV)QTY->97EG<6%W+:W4313Q-M=&Z@_P!1[]Z^AZI:EI&G
MZQ`(=0M(YU'W2PPR\@\,.1T'0\T`?/U%>@:M\,+B-FDTFZ66,*3Y5P=KY`'`
M8#!).>NW''UKBK_2[_2Y?+OK2:W8L54R(0&(Z[3T(Z<CUI@5****`"BBB@`H
MHHH`****`"BI[6SNKZ4Q6EM-<2!=Q6*,N0/7`[<BNQT?X:ZC<RA]4=;.%6Y1
M6#R,..F.`",\Y/(Z4`<3'&\TJ11(SR.P5549+$]`!W-=QX?^'%S?(+C5WDLX
MC@K"H'F,",Y/7;R1P03UX%=YH?AC3/#ZL;*)C,Z[7GE;<[#.<>@'T`S@9SBM
MBD!6L=/M-,MEM[*WC@B'\*#&3@#)/<X`Y/-6:**`,WQ#_P`BUJO_`%YS?^@&
MO`Z^BKBWBN[:6WG7=%*AC=<D94C!&1[5X3K'A[4]"E*WULRQEL+,OS1MUQAO
M4X)P<'':@#+HHHI@%%%6[#2[_5)?+L;2:X8,%8QH2%)Z;CT`Z\GTH`].^&'_
M`"+5S_U^-_Z`E=K63X:T;^P="M[%C&TJY:5XUP&8G/XX&!D]@.G2M:D`4444
M`%%%%`'SC175>*/!=_I%W<7%K;M-II8NCQY8Q+R<,,DX`'WNG3G)Q7*TP"BB
MB@`HHK0TW0]3U=@+"QFF4L5WA<("!G!8\`X]3W%`'K?@+_D2]/\`^VG_`*,:
MNCK-T#2_[&T*TT\MN:)/G.<@L26;'`XR3CVK2I`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`'.>/?^1+U#_MG_Z,6O%*]Z\1Z4^M:!=Z?%(L<DJC:S#(
MR&#`'V.,9_G7BNI:'J>D,1?V,T*A@N\KE"2,X##@G'H>QI@9]%%%`!1110`5
M]'5X[X3\'ZAJ6H6MY<6WE:>CK(S3IQ*!@[0IZA@>O3&>O2O8J0!1110`4444
M`%%%%`!1110`4444`>?^)?AREPSW>B%8Y68L]LYPAXZ)QP<]CQSU`&*\UN+>
M>TG:&XADAE7&Z.12K#(SR#[5]%5FZSH6GZ];""_AW[,F.13AHR1C(/\`0Y'`
MR#B@#P.BNZU;X9ZA;O))ID\=U%U6.0[).O3^Z<#'.1GGBN,NK.ZL91%=VTUO
M(5W!98RA(]<'MP:8$%%%%`!1110`4444`%%%%`!16IIOAS6-64/9:?-)&5+"
M0C8A`.#AFP"<]L^OI7>:+\,[:#$NL3_:7_YXPDJ@Z]6X8]CQC!'>@#S_`$G1
M;_6[M;>Q@9SN`>0@[(P<\L>PX/UQQDUZIX:\#V&B*EQ<A;J_V@EW`*1L#GY`
M1P>G)YXXQDBNFM[>"T@6&WACAB7.V.-0JC)SP![U)2`****`"N*^)_\`R+5M
M_P!?B_\`H#UVM8_B?0QX@T26R#*DP820NV<*X]<=B"1WQG.#B@#PFBK=_I=_
MI<OEWUI-;L6*J9$(#$==IZ$=.1ZU4I@%%%%`!7M?@+_D2]/_`.VG_HQJ\ATW
M2-0UB<PZ?:23L/O%1A5X)Y8\#H>IYKV_0-+_`+&T*TT\MN:)/G.<@L26;'`X
MR3CVH`TJ***0!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!5:[T^RO]GVRSM[C9G9YT2OMSUQD<=!5FB@#-_X1[1?^@/I__@,G^%'_
M``CVB_\`0'T__P`!D_PK2HH`I6^C:7:3K-;Z;9PRKG;)'`JL,C'!`]*NT44`
M%%%%`!1110`5XAXSU9=7\37,T4F^WBQ#">,;5ZD$=06+$'T->K^*[]]-\+ZA
M=1;O,$>Q2K;2I8A0P/J-V?PKPF@`HHHI@%%%%`!7H?PX\-Q7&[6KR'<(WVVH
M8'&X=7QCG!P`<\$'N!7!V=J]]?6]I$5$D\BQ*6/`+'`S[<U[]I]C!IFGP65N
MN(H4"+P,GW..Y/)]S0!9HHHI`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`#9(TFB>*5%>-U*LK#(8'J".XKPOQ3I(T7Q%=6<:L(-P>'*D#8W(`SG('*Y
M_P!DU[M7FGQ4MXEN=,N`O[V1)(V;)Y52I`Q]6;\Z`//****8!1110`5U'P^N
M)8?&-K'&V%F21)!@<KM+8_-0?PKEZZ3P%_R.FG_]M/\`T6U`'M5%%%(`HHHH
M`****`"BBB@#"NO!OAZ\E$DNEPJP7;B(M$,?12!GGK6!=?"W3GB`M-0NHI-W
M+2A9!CTP`O/3G-=Y10!YI<?"N=8&-OJT<DO&U9("BGGN03CCVJC_`,*PUO\`
MY^M/_P"_C_\`Q%>LT4`>3?\`"L-;_P"?K3_^_C__`!%2V_PNU1IU%Q?6<<7.
MYH]SL..P(&>?>O5**`//;?X5P+.IN-6DDBYW+'`$8\=B2<<^U;5C\/\`P_9;
M2]O)=.K[PUQ(3Z<8&%(X[@]:ZBB@".WMX+2!8;>&.&)<[8XU"J,G/`'O4E%%
M`!1110`4444`%%%%`%"30M(FE>672K%Y'8LS-;H2Q/4DXY-,_P"$>T7_`*`^
MG_\`@,G^%:5%`&;_`,(]HO\`T!]/_P#`9/\`"M".-(8DBB14C10JJHP%`Z`#
ML*=10`4444`%%%%`!1110`56N]/LK_9]LL[>XV9V>=$K[<]<9''059HH`S?^
M$>T7_H#Z?_X#)_A1_P`(]HO_`$!]/_\``9/\*TJ*`*$>A:1#*DL6E6*2(P96
M6W0%2.A!QP:OT44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`4)-"TB:5Y9=*L7D=BS,UNA+$]23CDTS_`(1[1?\`H#Z?_P"`R?X5I44`
M9O\`PCVB_P#0'T__`,!D_P`*LVFGV5AO^QV=O;[\;_)B5-V.F<#GJ:LT4`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!4=Q;P7<#0W$,<T38W1R*&4X.
M>0?>I**`.<O_``+X?O\`S&^Q?9Y7Q\]NQ3;C'1?NCIZ?KS6%=?"RU>4&TU2:
M*/;RLL0D.?7(*\=.,5Z!10!Y;=?"W44E`M-0M98]O+2AHSGTP`W'3G-0?\*P
MUO\`Y^M/_P"_C_\`Q%>LT4`>3?\`"L-;_P"?K3_^_C__`!%6;3X67K[_`+9J
M5O#C&SR4:3/KG.W';UKU"B@#@[7X6Z<D1%WJ%U+)NX:(+&,>F"&YZ\YKI+#P
MIH6FR^;:Z;")-P8-)F0J1T*EB=I^E;%%`!1110`4444`%%%%`!1110`50DT+
M2)I7EETJQ>1V+,S6Z$L3U)..35^B@#-_X1[1?^@/I_\`X#)_A3X]"TB&5)8M
M*L4D1@RLMN@*D="#C@U?HH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`.#^*5TB:
M18VA#>9+.95..,*I!S[_`#C]:\MKT#XIW2/?:=:`-YD4;RL<<88@#'O\A_2O
M/Z8!1110`4444`=9\.;3[3XMCEW[?LT+RXQG=D;,>WW\_A7L5>6_"V!&U>^G
M,RB1(`BQ=V#,"6'/0;0/^!#\?4J0!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%><?%;_F$?]MO_9*]'KROXGWWG:S:62M&RV\)<[3E@SGD'\%4
M_C[T`<+1113`****`"ND\!?\CII__;3_`-%M7-UU7P[M7N/%\$J%0MO')*^3
MR05V<>^7'ZT`>R4444@"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@#R;XG_\`(RVW_7FO_H;UQ5>C_%;_`)A'_;;_`-DKSBF`4444`%%%%`'8
M_#2XBA\4O'(V&FMG2,8/+95L?DI/X5Z[7SUI]]/IFH07MNV)87#KR<'V..Q'
M!]C7OFGWT&IZ?!>V[9BF0.O(R/8X[@\'W%("S1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`-DD2&)Y975(T4LS,<!0.I)["O`]<U(ZOK=Y?DL5FD
M)3<`"$'"@XXR%`%=S\0/%B>4^BZ?,WF;L74B'@#O'GN?7'ICG)`\VI@%%%%`
M!1110`5Z/\++#_D(:B\7]V".3=_P)QC/^YSCZ=Z\XKW/PEIG]D^&;*W9-LK)
MYLN8]C;FYPP]0"%Y_N_A0!MT444@"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@#D_B-:?:?"4DN_;]FF27&,[LG9CV^_G\*\=KZ'O+5+ZQN+2
M4L(YXVB8J>0&&#CWYKP'4+&?3-0GLKA<2PN4;@X/N,]B.1[&F!6HHHH`****
M`"NF\)>+7\-RRQ2PM/:3,I90^"A'5E'0G'4<9P.1BN9HH`^A[.\M[^TBNK65
M98)5W(Z]"/Z'V[5/7@.DZU?Z)=K<6,[(=P+QDG9(!GAAW')^F>,&O0M)^)ME
M<,L6J6S6K;1F:,ET)P<DC&0,XP!NZ^V:0'>454L-4L-4B\RQNX;A0H9A&X)4
M'IN'4'KP?2K=`!1110`4444`%%%%`!1110`45'<7$%I`TUQ-'#$N-TDC!5&3
MCDGWKE-6^(FCV"LEF6OYPQ7;'\J`@@<N1R.N"`<X_&@#KZ\]\7>/HE@:PT2?
M?(V5ENDR`@SC"'N3_>'`'3DY')>(/%VI>('*2/Y%H,@6\3':1G(W?WCP/;C@
M"L"@`HHHI@%%%%`!113HXWFE2*)&>1V"JJC)8GH`.YH`Z+P3H?\`;7B"/S8]
MUI;8EFR,AL?=4\$<GL>H#5[56%X3T%-!T2*)HU6[E4/<MCDM_=)R>%SCCCJ>
MYK=I`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5YU\
M2O#Y=4URW1<(HCNN0#C("MTY/.#S_=XP#7HM-DC2:)XI45XW4JRL,A@>H([B
M@#YSHKK_`!EX-?0Y6O;)6?37;D=3`3V/JOH?P/.">0I@%%%%`!1110`4444`
M.CD>&5)8G9)$8,K*<%2.A![&MNU\9>(;.(QQ:I,REMV90LIS]6!...E85%`'
M:V_Q.UF/REFM[.95P'.QE9P.O(.`3],>U:7_``M;_J"_^37_`-A7G%%`'J5K
M\4M.>(F[T^ZBDW<+$5D&/7)*\]>,5/\`\+/T7_GUU#_OVG_Q=>344`>L_P#"
MS]%_Y]=0_P"_:?\`Q=9\GQ502N(M'9HPQVLUQM)'8D;3@^V37FU%`'?7?Q3O
M7V?8]-MX<9W^<[29],8VX[^M9-]\0/$%[N"7$=JC)L*V\8'KSDY8'GL1TKEZ
M*`)[J\NKZ42W=S-<2!=H:60N0/3)[<FH***`"BBB@`HHHH`****`"O4O`W@U
M].:/5]15DNRI\B`\&,$8);_:()X[9YYZ5O"?P_3RHM0UJ-O,W!X[0]`/^F@[
MGH=OMSG)`]%I`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`#9(TFB>*5%>-U*LK#(8'J".XKR_P`2_#NXM6>ZT8-<0%BQ
MMOXXQC/!)^<=>.O3KR:]2HH`^<:*]M\0>#=,U]GGD5H+PK@7$?4X!`W#H1T]
M#P!D5YUJW@'6]->1H8/MMNO(D@Y8C.!E/O9Z$XR!GK3`Y>BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BKNFZ1J&L3F'3[22=A]XJ,*O!/
M+'@=#U/-=YH_PP"2B36+I9%5N(;8G##CJQ`..HP`/K0!PVDZ+?ZW=K;V,#.=
MP#R$'9&#GECV'!^N.,FO5/#7@>PT14N+D+=7^T$NX!2-@<_(".#TY//'&,D5
MT=G9V]A:16MK$L4$2[41>@']3[]ZGI`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%#4M#TS5U(O[
M&&9BH7>5PX`.<!AR!GT/<UR&I_#"TEW2:9>20-\Q$4PWKG^%01@@=LG<?Z]]
M10!XS??#_P`066XI;QW2*F\M;R`^O&#AB>.P/6L"[T^]L-GVRSN+??G9YT3)
MNQUQD<]17T+10!\XT5]`W&C:7=SM-<:;9S2MC=))`K,<#')(]*S;CP3X<N9V
MFDTN,,V,B-VC7ICA5(`_*F!XA17H?CSPSI&C:'!<:?:>3*URL9;S';*E6.,$
MGN!7GE`!1110`4444`%%>NZ-X*\/7>AZ?<3Z?NEEMHY';SI!EBH).`WK6S:^
M%-`LXC'%I-JREMV94\TY^K9...E`'A-;%KX4U^\E,<6DW2L%W9E3RACZM@9Y
MZ5[E;V\%I`L-O#'#$N=L<:A5&3G@#WJ2D!Y78_##4IMK7MY;VRE,X0&1@W'R
MD<#UY!/2NNTWP%H&G,'-LUW(&)#73;P`1C&T`*1]1_2NFHH`;'&D,211(J1H
MH5548"@=`!V%.HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
>HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
